Dietary phytochemicals alter epigenetic events and signaling pathways for inhibition of metastasis cascade: Phytoblockers of metastasis cascade

Cancer and Metastasis Reviews

Volumn 33, Issue 1, 2014, Pages 41-85

  Singh, B N ^a   Singh, Harikesh Bahadur ^b   Singh, A ^b   Naqvi, Alim H ^c   Singh, Braj Raj ^c  

^a Research and Development Division Sowbhagya Biotech Private Limited Cherlapally   (India)

^b BANARAS HINDU UNIVERSITY   (India)

^c ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Cancer; Combine therapy; Dietary phytochemicals; Epigenetic modifications; Metastasis; Micro RNAs; Nanochemoprevention; Signaling pathways

Indexed keywords

BETA CATENIN; DIETARY PHYTOCHEMICAL; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; HISTONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; LIPOXYGENASE; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PLANT MEDICINAL PRODUCT; PROSTAGLANDIN SYNTHASE; PROTEIN KINASE B; SONIC HEDGEHOG PROTEIN; STAT PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FOXO; UNCLASSIFIED DRUG; WNT PROTEIN;

CANCER THERAPY; DIET; DNA METHYLATION; DRUG POTENTIATION; DRUG SCREENING; EPIGENETICS; HISTONE MODIFICATION; HUMAN; METASTASIS; METASTASIS INHIBITION; METASTASIS POTENTIAL; MOLECULAR DOCKING; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SHAPE SIMILARITY SCREENING METHOD; SIGNAL TRANSDUCTION; VIRTUAL SCREENING METHOD; BIOLOGICAL MODEL; CELL PROLIFERATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; NEOPLASMS; PATHOLOGY;

CELL PROLIFERATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MODELS, GENETIC; NEOPLASM METASTASIS; NEOPLASMS; PHYTOCHEMICALS; SIGNAL TRANSDUCTION;

EID: 84899965767     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-013-9457-1     Document Type: Review

References (503)

1. Raffoul, J. J., Wang, Y., Kucuk, O., Forman, J. D., Sarkar, F. H., & Hillman, G. G. (2006). Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest. BMC Cancer, 6, 107.
2. Sarkar, F. H. (2010). Nutraceuticals and cancer. Preface. Cancer Metastasis Reviews, 29(3), 381-382.
3. Sarkar, F. H., Li, Y., Wang, Z., & Kong, D. (2009). Cellular signaling perturbation by natural products. Cellular Signalling, 21(11), 1541-1547.
4. Singh, B. N., Shankar, S., & Srivastava, R. K. (2011). Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochemical Pharmacology, 82(12), 1807-1821.
5. Singh, B. N., Kumar, D., Shankar, S., & Srivastava, R. K. (2012). Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells. Biochemical Pharmacology, 84(9), 1154-1163.
6. Subramaniam, D., Ponnurangam, S., Ramamoorthy, P., Standing, D., Battafarano, R. J., Anant, S., et al. (2012). Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling. PLoS One, 7(2), e30590.
7. Aggarwal, B. B., Sethi, G., Ahn, K. S., Sandur, S. K., Pandey, M. K., Kunnumakkara, A. B., et al. (2006). Targeting signal-transducer-and-activator- of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Annals of the New York Academy of Sciences, 1091, 151-169.
8. Aggarwal, B. B., & Shishodia, S. (2006). Molecular targets of dietary agents for prevention and therapy of cancer. Biochemical Pharmacology, 71(10), 1397-1421.
9. Aggarwal, B. B., Ichikawa, H., Garodia, P., Weerasinghe, P., Sethi, G., Bhatt, I. D., et al. (2006). From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer. Expert Opinion on Therapeutic Targets, 10(1), 87-118.
10. Singh, B. N., Singh, B. R., Sarma, B. K., & Singh, H. B. (2009). Potential chemoprevention of N-nitrosodiethylamine-induced hepatocarcinogenesis by polyphenolics from Acacia nilotica bark. Chemico-Biological Interactions, 181(1), 20-28.
11. Singh, B. N., Singh, B. R., Singh, R. L., Prakash, D., Singh, D. P., Sarma, B. K., et al. (2009). Polyphenolics from various extracts/fractions of red onion (Allium cepa) peel with potent antioxidant and antimutagenic activities. Food and Chemical Toxicology, 47(6), 1161-1167.
12. Singh, B. N., Singh, B. R., Singh, R. L., Prakash, D., Sarma, B. K., & Singh, H. B. (2009). Antioxidant and anti-quorum sensing activities of green pod of Acacia nilotica L. Food and Chemical Toxicology, 47(4), 778-786.
13. Singh, B. N., Singh, B. R., Singh, R. L., Prakash, D., Dhakarey, R., Upadhyay, G., et al. (2009). Oxidative DNA damage protective activity, antioxidant and anti-quorum sensing potentials of Moringa oleifera. Food and Chemical Toxicology, 47(6), 1109-1116.
14. Prakash, D., Suri, S., Upadhyay, G., & Singh, B. N. (2007). Total phenol, antioxidant and free radical scavenging activities of some medicinal plants. International Journal of Food Sciences and Nutrition, 58(1), 18-28.
15. Prakash, D., Singh, B. N., & Upadhyay, G. (2007). Antioxidant and free radical scavenging activities of phenols from onion (Allium cepa). Food Chemistry, 102(4), 1389-1393.
16. Singh, H. B., Singh, B. N., Singh, S. P., & Nautiyal, C. S. (2010). Solid-state cultivation of Trichoderma harzianum NBRI-1055 for modulating natural antioxidants in soybean seed matrix. Bioresource Technology, 101(16), 6444-6453.
17. Meeran, S. M., Ahmed, A., & Tollefsbol, T. O. (2010). Epigenetic targets of bioactive dietary components for cancer prevention and therapy. Clinical Epigenetics, 1(3-4), 101-116. doi: 10.1007/s13148-010-0011-5.
18. Sarkar, F. H., Li, Y., Wang, Z., & Kong, D. (2010). The role of nutraceuticals in the regulation of Wnt and Hedgehog signaling in cancer. Cancer Metastasis Reviews, 29(3), 383-394.
19. Banerjee, S., Padhye, S., Azmi, A., Wang, Z., Philip, P. A., Kucuk, O., et al. (2010). Review on molecular and therapeutic potential of thymoquinone in cancer. Nutrition and Cancer, 62(7), 938-946.
20. Sung, B., Prasad, S., Yadav, V. R., & Aggarwal, B. B. (2012). Cancer cell signaling pathways targeted by spice-derived nutraceuticals. Nutrition and Cancer, 64(2), 173-197.
21. Singh, S., & Aggarwal, B. B. (1995). Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. Journal of Biological Chemistry, 270(42), 24995-25000.
22. Ren, J., Singh, B. N., Huang, Q., Li, Z., Gao, Y., Mishra, P., et al. (2011). DNA hypermethylation as a chemotherapy target. Cellular Signalling, 23(7), 1082-1093.
23. Hadi, S. M., Bhat, S. H., Azmi, A. S., Hanif, S., Shamim, U., & Ullah, M. F. (2007). Oxidative breakage of cellular DNA by plant polyphenols: a putative mechanism for anticancer properties. Seminars in Cancer Biology, 17(5), 370-376.
24. Nazeem, S., Azmi, A. S., Hanif, S., Ahmad, A., Mohammad, R. M., Hadi, S. M., et al. (2009). Plumbagin induces cell death through a copper-redox cycle mechanism in human cancer cells. Mutagenesis, 24(5), 413-418.
25. Bhat, S. H., Azmi, A. S., & Hadi, S. M. (2007). Prooxidant DNA breakage induced by caffeic acid in human peripheral lymphocytes: involvement of endogenous copper and a putative mechanism for anticancer properties. Toxicology and Applied Pharmacology, 218(3), 249-255.
26. Bhat, S. H., Azmi, A. S., Hanif, S., & Hadi, S. M. (2006). Ascorbic acid mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: a putative mechanism for anticancer properties. International Journal of Biochemistry and Cell Biology, 38(12), 2074-2081.
27. Azmi, A. S., Bhat, S. H., Hanif, S., & Hadi, S. M. (2006). Plant polyphenols mobilize endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: a putative mechanism for anticancer properties. FEBS Letters, 580(2), 533-538.
28. Azmi, A. S., Bhat, S. H., & Hadi, S. M. (2005). Resveratrol-Cu(II) induced DNA breakage in human peripheral lymphocytes: implications for anticancer properties. FEBS Letters, 579(14), 3131-3135.
29. Uddin, Q., Malik, A., Azam, S., Hadi, N., Azmi, A. S., Parveen, N., et al. (2004). The biflavonoid, amentoflavone degrades DNA in the presence of copper ions. Toxicology in Vitro, 18(4), 435-440.
30. Linder, M. C. (2012). The relationship of copper to DNA damage and damage prevention in humans. Mutation Research, 733(1-2), 83-91.
31. Hadi, S. M., Asad, S. F., Singh, S., & Ahmad, A. (2000). Putative mechanism for anticancer and apoptosis-inducing properties of plant-derived polyphenolic compounds. IUBMB Life, 50(3), 167-171.
32. Ullah, M. F., Shamim, U., Hanif, S., Azmi, A. S., & Hadi, S. M. (2009). Cellular DNA breakage by soy isoflavone genistein and its methylated structural analogue biochanin A. Molecular Nutrition & Food Research, 53(11), 1376-1385.
33. Fraga, M. F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., et al. (2005). Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nature Genetics, 37(4), 391-400.
34. Farazi, T. A., Spitzer, J. I., Morozov, P., & Tuschl, T. (2011). miRNAs in human cancer. Journal of Pathology, 223(2), 102-115.
35. Sethi, S., Kong, D., Land, S., Dyson, G., Sakr, W. A., & Sarkar, F. H. (2013). Comprehensive molecular oncogenomic profiling and miRNA analysis of prostate cancer. American Journal of Translational Research, 5(2), 200-211.
36. Fabbri, M., Garzon, R., Cimmino, A., Liu, Z., Zanesi, N., Callegari, E., et al. (2007). MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proceedings of the National Academy of Sciences of the United States of America, 104(40), 15805-15810.
37. Parasramka, M. A., Ho, E., Williams, D. E., & Dashwood, R. H. (2012). MicroRNAs, diet, and cancer: new mechanistic insights on the epigenetic actions of phytochemicals. Molecular Carcinogenesis, 51(3), 213-230.
38. Zhang, J., Zhang, T., Ti, X., Shi, J., Wu, C., Ren, X., et al. (2010). Curcumin promotes apoptosis in A549/DDP multidrug-resistant human lung adenocarcinoma cells through an miRNA signaling pathway. Biochemical and Biophysical Research Communications, 399(1), 1-6.
39. Ali, S., Ahmad, A., Banerjee, S., Padhye, S., Dominiak, K., Schaffert, J. M., et al. (2010). Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF. Cancer Research, 70(9), 3606-3617.
40. Roy, S., Yu, Y., Padhye, S. B., Sarkar, F. H., & Majumdar, A. P. (2013). Difluorinated-curcumin (CDF) restores PTEN expression in colon cancer cells by down-regulating miR-21. PLoS One, 8(7), e68543.
41. Tili, E., Michaille, J. J., Alder, H., Volinia, S., Delmas, D., Latruffe, N., et al. (2010). Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFbeta signaling pathway in SW480 cells. Biochemical Pharmacology, 80(12), 2057-2065.
42. Tili, E., Michaille, J. J., Adair, B., Alder, H., Limagne, E., Taccioli, C., et al. (2010). Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD. Carcinogenesis, 31(9), 1561-1566.
43. Wen, X. Y., Wu, S. Y., Li, Z. Q., Liu, Z. Q., Zhang, J. J., Wang, G. F., et al. (2009). Ellagitannin (BJA3121), an anti-proliferative natural polyphenol compound, can regulate the expression of miRNAs in HepG2 cancer cells. Phytotherapy Research, 23(6), 778-784.
44. Li, Y., Vandenboom, T. G., 2nd, Wang, Z., Kong, D., Ali, S., Philip, P. A., et al. (2010). miR-146a suppresses invasion of pancreatic cancer cells. Cancer Research, 70(4), 1486-1495.
45. Li, Y., VandenBoom, T. G., 2nd, Kong, D., Wang, Z., Ali, S., Philip, P. A., et al. (2009). Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Research, 69(16), 6704-6712.
46. Ma, J., Cheng, L., Liu, H., Zhang, J., Shi, Y., Zeng, F., et al. (2013). Genistein down-regulates miR-223 expression in pancreatic cancer cells. Current Drug Targets, 14(10), 1150-1156.
47. Majid, S., Dar, A. A., Saini, S., Chen, Y., Shahryari, V., Liu, J., et al. (2010). Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. Cancer Research, 70(7), 2809-2818.
48. Sun, Q., Cong, R., Yan, H., Gu, H., Zeng, Y., Liu, N., et al. (2009). Genistein inhibits growth of human uveal melanoma cells and affects microRNA-27a and target gene expression. Oncology Reports, 22(3), 563-567.
49. Izzotti, A., Calin, G. A., Steele, V. E., Cartiglia, C., Longobardi, M., Croce, C. M., et al. (2010). Chemoprevention of cigarette smoke-induced alterations of microRNA expression in rat lungs. Cancer Prevention Research (Philadelphia, Pa.), 3(1), 62-72.
50. Izzotti, A., Calin, G. A., Arrigo, P., Steele, V. E., Croce, C. M., & De Flora, S. (2009). Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB Journal, 23(3), 806-812.
51. Tsang, W. P., & Kwok, T. T. (2010). Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells. Journal of Nutrition and Biochemistry, 21(2), 140-146.
52. Jones, P. A., & Baylin, S. B. (2007). The epigenomics of cancer. Cell, 128(4), 683-692.
53. Das, P. M., & Singal, R. (2004). DNA methylation and cancer. Journal of Clinical Oncology, 22(22), 4632-4642.
54. Fang, M. Z., Wang, Y., Ai, N., Hou, Z., Sun, Y., Lu, H., et al. (2003). Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Research, 63(22), 7563-7570.
55. Majid, S., Dar, A. A., Ahmad, A. E., Hirata, H., Kawakami, K., Shahryari, V., et al. (2009). BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis, 30(4), 662-670.
56. Fang, M., Chen, D., & Yang, C. S. (2007). Dietary polyphenols may affect DNA methylation. Journal of Nutrition, 137(1 Suppl), 223S-228S.
57. Shu, L., Khor, T. O., Lee, J. H., Boyanapalli, S. S., Huang, Y., Wu, T. Y., et al. (2011). Epigenetic CpG demethylation of the promoter and reactivation of the expression of Neurog1 by curcumin in prostate LNCaP cells. The AAPS Journal, 13(4), 606-614.
58. Meeran, S. M., Patel, S. N., & Tollefsbol, T. O. (2010). Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines. PLoS One, 5(7), e11457.
59. Papoutsis, A. J., Lamore, S. D., Wondrak, G. T., Selmin, O. I., & Romagnolo, D. F. (2010). Resveratrol prevents epigenetic silencing of BRCA-1 by the aromatic hydrocarbon receptor in human breast cancer cells. Journal of Nutrition, 140(9), 1607-1614.
60. Pandey, M., Shukla, S., & Gupta, S. (2010). Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells. International Journal of Cancer, 126(11), 2520-2533.
61. Gao, Z., Xu, Z., Hung, M. S., Lin, Y. C., Wang, T., Gong, M., et al. (2009). Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells. Anticancer Research, 29(6), 2025-2030.
62. Berletch, J. B., Liu, C., Love, W. K., Andrews, L. G., Katiyar, S. K., & Tollefsbol, T. O. (2008). Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG. Journal of Cellular Biochemistry, 103(2), 509-519.
63. Lee, W. J., Shim, J. Y., & Zhu, B. T. (2005). Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Molecular Pharmacology, 68(4), 1018-1030.
64. Kato, K., Long, N. K., Makita, H., Toida, M., Yamashita, T., Hatakeyama, D., et al. (2008). Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. British Journal of Cancer, 99(4), 647-654.
65. Mittal, A., Piyathilake, C., Hara, Y., & Katiyar, S. K. (2003). Exceptionally high protection of photocarcinogenesis by topical application of (-)-epigallocatechin-3-gallate in hydrophilic cream in SKH-1 hairless mouse model: relationship to inhibition of UVB-induced global DNA hypomethylation. Neoplasia, 5(6), 555-565.
66. Lee, W. J., & Zhu, B. T. (2006). Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis, 27(2), 269-277.
67. Traka, M., Gasper, A. V., Smith, J. A., Hawkey, C. J., Bao, Y., & Mithen, R. F. (2005). Transcriptome analysis of human colon Caco-2 cells exposed to sulforaphane. Journal of Nutrition, 135(8), 1865-1872.
68. Majid, S., Kikuno, N., Nelles, J., Noonan, E., Tanaka, Y., Kawamoto, K., et al. (2008). Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Cancer Research, 68(8), 2736-2744.
69. Qin, W., Zhu, W., Shi, H., Hewett, J. E., Ruhlen, R. L., MacDonald, R. S., et al. (2009). Soy isoflavones have an antiestrogenic effect and alter mammary promoter hypermethylation in healthy premenopausal women. Nutrition and Cancer, 61(2), 238-244.
70. Liu, H. L., Chen, Y., Cui, G. H., & Zhou, J. F. (2005). Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation. Acta Pharmacologica Sinica, 26(5), 603-609.
71. Kang, S. K., Cha, S. H., & Jeon, H. G. (2006). Curcumin-induced histone hypoacetylation enhances caspase-3-dependent glioma cell death and neurogenesis of neural progenitor cells. Stem Cells and Development, 15(2), 165-174.
72. Pollack, B. P., Sapkota, B., & Boss, J. M. (2009). Ultraviolet radiation-induced transcription is associated with gene-specific histone acetylation. Photochemistry and Photobiology, 85(3), 652-662.
73. Yun, J. M., Jialal, I., & Devaraj, S. (2011). Epigenetic regulation of high glucose-induced proinflammatory cytokine production in monocytes by curcumin. Journal of Nutrition and Biochemistry, 22(5), 450-458.
74. Chiu, J., Khan, Z. A., Farhangkhoee, H., & Chakrabarti, S. (2009). Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB. Nutrition, 25(9), 964-972.
75. Myzak, M. C., Karplus, P. A., Chung, F. L., & Dashwood, R. H. (2004). A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Research, 64(16), 5767-5774.
76. Myzak, M. C., Dashwood, W. M., Orner, G. A., Ho, E., & Dashwood, R. H. (2006). Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice. FASEB Journal, 20(3), 506-508.
77. Myzak, M. C., Tong, P., Dashwood, W. M., Dashwood, R. H., & Ho, E. (2007). Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Experimental Biology and Medicine (Maywood, N.J.), 232(2), 227-234.
78. Choi, K. C., Jung, M. G., Lee, Y. H., Yoon, J. C., Kwon, S. H., Kang, H. B., et al. (2009). Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation. Cancer Research, 69(2), 583-592.
79. Nihal, M., Roelke, C. T., & Wood, G. S. (2010). Anti-melanoma effects of vorinostat in combination with polyphenolic antioxidant (-)- epigallocatechin-3-gallate (EGCG). Pharmaceutical Research, 27(6), 1103-1114.
80. Murugan, R. S., Vinothini, G., Hara, Y., & Nagini, S. (2009). Black tea polyphenols target matrix metalloproteinases, RECK, proangiogenic molecules and histone deacetylase in a rat hepatocarcinogenesis model. Anticancer Research, 29(6), 2301-2305.
81. Kaeberlein, M., McDonagh, T., Heltweg, B., Hixon, J., Westman, E. A., Caldwell, S. D., et al. (2005). Substrate-specific activation of sirtuins by resveratrol. Journal of Biological Chemistry, 280(17), 17038-17045.
82. King, T. D., Suto, M. J., & Li, Y. (2012). The Wnt/beta-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer. Journal of Cellular Biochemistry, 113(1), 13-18.
83. Cai, C., & Zhu, X. (2012). The Wnt/beta-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer. Molecular Medicine Reports, 5(5), 1191-1196.
84. Ysebaert, L., Chicanne, G., Demur, C., De Toni, F., Prade-Houdellier, N., Ruidavets, J. B., et al. (2006). Expression of beta-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis. Leukemia, 20(7), 1211-1216.
85. Khan, N. I., Bradstock, K. F., & Bendall, L. J. (2007). Activation of Wnt/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia. British Journal of Haematology, 138(3), 338-348.
86. Nout, R. A., Bosse, T., Creutzberg, C. L., Jurgenliemk-Schulz, I. M., Jobsen, J. J., Lutgens, L. C., et al. (2012). Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/beta-catenin and P53 pathway activation. Gynecologic Oncology, 126(3), 466-473.
87. Zhang, J., Gill, A. J., Issacs, J. D., Atmore, B., Johns, A., Delbridge, L. W., et al. (2012). The Wnt/beta-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer. Human Pathology, 43(7), 1044-1050.
88. Chien, A. J., Moore, E. C., Lonsdorf, A. S., Kulikauskas, R. M., Rothberg, B. G., Berger, A. J., et al. (2009). Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model. Proceedings of the National Academy of Sciences of the United States of America, 106(4), 1193-1198.
89. Yoshioka, S., King, M. L., Ran, S., Okuda, H., MacLean, J. A., 2nd, McAsey, M. E., et al. (2012). WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/beta-catenin pathway. Molecular Cancer Research, 10(3), 469-482.
90. Hallett, R. M., Kondratyev, M. K., Giacomelli, A. O., Nixon, A. M., Girgis-Gabardo, A., Ilieva, D., et al. (2012). Small molecule antagonists of the Wnt/beta-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer. PLoS One, 7(3), e33976.
91. Laezza, C., D'Alessandro, A., Paladino, S., Maria Malfitano, A., Chiara Proto, M., Gazzerro, P., et al. (2012). Anandamide inhibits the Wnt/beta-catenin signalling pathway in human breast cancer MDA MB 231 cells. European Journal of Cancer, 48(16), 3112-3122.
92. Bush, B. M., Brock, A. T., Deng, J. A., Nelson, R. A., Jr., & Sumter, T. F. (2012). The Wnt/beta-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer. Cell Biochemistry and Function, 31(3), 228-236.
93. Jingushi, K., Takahashi-Yanaga, F., Yoshihara, T., Shiraishi, F., Watanabe, Y., Hirata, M., et al. (2012). DIF-1 inhibits the Wnt/beta-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines. Biochemical Pharmacology, 83(1), 47-56.
94. Scholer-Dahirel, A., & McLaughlin, M. E. (2012). Determinants of Wnt/beta-catenin pathway dependency in colorectal cancer. Cell Cycle, 11(1), 9-10.
95. Yang, W., Yan, H. X., Chen, L., Liu, Q., He, Y. Q., Yu, L. X., et al. (2008). Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells. Cancer Research, 68(11), 4287-4295.
96. Yang, L., Chen, Y., Cui, T., Knosel, T., Zhang, Q., Albring, K. F., et al. (2012). Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/beta-catenin signaling pathway in human lung cancer. Carcinogenesis, 33(10), 1863-1870.
97. Lim, Y. C., Kang, H. J., Kim, Y. S., & Choi, E. C. (2012). All-trans-retinoic acid inhibits growth of head and neck cancer stem cells by suppression of Wnt/beta-catenin pathway. European Journal of Cancer, 48(17), 3310-3318.
98. Sarbassov, D. D., Ali, S. M., Kim, D. H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., et al. (2004). Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Current Biology, 14(14), 1296-1302.
99. Smalley, M. J., & Dale, T. C. (1999). Wnt signalling in mammalian development and cancer. Cancer Metastasis Reviews, 18(2), 215-230.
100. MacDonald, B. T., Tamai, K., & He, X. (2009). Wnt/beta-catenin signaling: components, mechanisms, and diseases. Developmental Cell, 17(1), 9-26.
101. Clevers, H. (2006). Wnt/beta-catenin signaling in development and disease. Cell, 127(3), 469-480.
102. Woodward, W. A., Chen, M. S., Behbod, F., Alfaro, M. P., Buchholz, T. A., & Rosen, J. M. (2007). WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proceedings of the National Academy of Sciences of the United States of America, 104(2), 618-623.
103. Salama, P., & Platell, C. (2009). Colorectal cancer stem cells. ANZ Journal of Surgery, 79(10), 697-702.
104. Kanwar, S. S., Yu, Y., Nautiyal, J., Patel, B. B., & Majumdar, A. P. (2010). The Wnt/beta-catenin pathway regulates growth and maintenance of colonospheres. Molecular Cancer, 9, 212.
105. Nelson, W. J., & Nusse, R. (2004). Convergence of Wnt, beta-catenin, and cadherin pathways. Science, 303(5663), 1483-1487.
106. Lin, S. Y., Xia, W., Wang, J. C., Kwong, K. Y., Spohn, B., Wen, Y., et al. (2000). Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proceedings of the National Academy of Sciences of the United States of America, 97(8), 4262-4266.
107. Liu, C., Li, Y., Semenov, M., Han, C., Baeg, G. H., Tan, Y., et al. (2002). Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell, 108(6), 837-847.
108. Cohen, P., & Frame, S. (2001). The renaissance of GSK3. Nature Reviews Molecular Cell Biology, 2(10), 769-776.
109. Zhang, Y., & Chen, H. (2011). Genistein attenuates WNT signaling by up-regulating sFRP2 in a human colon cancer cell line. Experimental Biology and Medicine (Maywood, N.J.), 236(6), 714-722.
110. Li, Y., Wang, Z., Kong, D., Li, R., Sarkar, S. H., & Sarkar, F. H. (2008). Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells. Journal of Biological Chemistry, 283(41), 27707-27716.
111. Tarapore, R. S., Siddiqui, I. A., & Mukhtar, H. (2012). Modulation of Wnt/beta-catenin signaling pathway by bioactive food components. Carcinogenesis, 33(3), 483-491.
112. Shehzad, A., Ha, T., Subhan, F., & Lee, Y. S. (2011). New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. European Journal of Nutrition, 50(3), 151-161.
113. Zhang, X., Yin, W. K., Shi, X. D., & Li, Y. (2011). Curcumin activates Wnt/beta-catenin signaling pathway through inhibiting the activity of GSK-3beta in APPswe transfected SY5Y cells. European Journal of Pharmaceutical Sciences, 42(5), 540-546.
114. Syed, D. N., Afaq, F., Maddodi, N., Johnson, J. J., Sarfaraz, S., Ahmad, A., et al. (2011). Inhibition of human melanoma cell growth by the dietary flavonoid fisetin is associated with disruption of Wnt/beta-catenin signaling and decreased Mitf levels. Journal of Investigative Dermatology, 131(6), 1291-1299.
115. Chen, H. J., Hsu, L. S., Shia, Y. T., Lin, M. W., & Lin, C. M. (2012). The beta-catenin/TCF complex as a novel target of resveratrol in the Wnt/beta-catenin signaling pathway. Biochemical Pharmacology, 84(9), 1143-1153.
116. Vanamala, J., Reddivari, L., Radhakrishnan, S., & Tarver, C. (2010). Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways. BMC Cancer, 10, 238.
117. Sangeetha, N., Aranganathan, S., Panneerselvam, J., Shanthi, P., Rama, G., & Nalini, N. (2010). Oral supplementation of silibinin prevents colon carcinogenesis in a long term preclinical model. European Journal of Pharmacology, 643(1), 93-100.
118. Tarapore, R. S., Siddiqui, I. A., Saleem, M., Adhami, V. M., Spiegelman, V. S., & Mukhtar, H. (2010). Specific targeting of Wnt/beta-catenin signaling in human melanoma cells by a dietary triterpene lupeol. Carcinogenesis, 31(10), 1844-1853.
119. Palmer, H. G., Gonzalez-Sancho, J. M., Espada, J., Berciano, M. T., Puig, I., Baulida, J., et al. (2001). Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. Journal of Cell Biology, 154(2), 369-387.
120. Tang, F. Y., Shih, C. J., Cheng, L. H., Ho, H. J., & Chen, H. J. (2008). Lycopene inhibits growth of human colon cancer cells via suppression of the Akt signaling pathway. Molecular Nutrition & Food Research, 52(6), 646-654.
121. Su, Y., & Simmen, R. C. (2009). Soy isoflavone genistein upregulates epithelial adhesion molecule E-cadherin expression and attenuates beta-catenin signaling in mammary epithelial cells. Carcinogenesis, 30(2), 331-339.
122. Su, Y., Simmen, F. A., Xiao, R., & Simmen, R. C. (2007). Expression profiling of rat mammary epithelial cells reveals candidate signaling pathways in dietary protection from mammary tumors. Physiological Genomics, 30(1), 8-16.
123. Wagner, J., & Lehmann, L. (2006). Estrogens modulate the gene expression of Wnt-7a in cultured endometrial adenocarcinoma cells. Molecular Nutrition & Food Research, 50(4-5), 368-372.
124. Kuang, H. B., Miao, C. L., Guo, W. X., Peng, S., Cao, Y. J., & Duan, E. K. (2009). Dickkopf-1 enhances migration of HEK293 cell by beta-catenin/E-cadherin degradation. Frontiers in Bioscience (Landmark Ed), 14, 2212-2220.
125. Park, C. H., Hahm, E. R., Park, S., Kim, H. K., & Yang, C. H. (2005). The inhibitory mechanism of curcumin and its derivative against beta-catenin/Tcf signaling. FEBS Letters, 579(13), 2965-2971.
126. Kakarala, M., Brenner, D. E., Korkaya, H., Cheng, C., Tazi, K., Ginestier, C., et al. (2010). Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Research and Treatment, 122(3), 777-785.
127. Jaiswal, A. S., Marlow, B. P., Gupta, N., & Narayan, S. (2002). Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene, 21(55), 8414-8427.
128. Yan, C., Jamaluddin, M. S., Aggarwal, B., Myers, J., & Boyd, D. D. (2005). Gene expression profiling identifies activating transcription factor 3 as a novel contributor to the proapoptotic effect of curcumin. Molecular Cancer Therapeutics, 4(2), 233-241.
129. Ryu, M. J., Cho, M., Song, J. Y., Yun, Y. S., Choi, I. W., Kim, D. E., et al. (2008). Natural derivatives of curcumin attenuate the Wnt/beta-catenin pathway through down-regulation of the transcriptional coactivator p300. Biochemical and Biophysical Research Communications, 377(4), 1304-1308.
130. Bose, M., Hao, X., Ju, J., Husain, A., Park, S., Lambert, J. D., et al. (2007). Inhibition of tumorigenesis in ApcMin/+ mice by a combination of (-)-epigallocatechin-3-gallate and fish oil. Journal of Agricultural and Food Chemistry, 55(19), 7695-7700.
131. Kim, J., Zhang, X., Rieger-Christ, K. M., Summerhayes, I. C., Wazer, D. E., Paulson, K. E., et al. (2006). Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1. Journal of Biological Chemistry, 281(16), 10865-10875.
132. Reguart, N., He, B., Taron, M., You, L., Jablons, D. M., & Rosell, R. (2005). The role of Wnt signaling in cancer and stem cells. Future Oncology, 1(6), 787-797.
133. Khor, T. O., Hu, R., Shen, G., Jeong, W. S., Hebbar, V., Chen, C., et al. (2006). Pharmacogenomics of cancer chemopreventive isothiocyanate compound sulforaphane in the intestinal polyps of ApcMin/+ mice. Biopharmaceutics and Drug Disposition, 27(9), 407-420.
134. Park, S. Y., Kim, G. Y., Bae, S. J., Yoo, Y. H., & Choi, Y. H. (2007). Induction of apoptosis by isothiocyanate sulforaphane in human cervical carcinoma HeLa and hepatocarcinoma HepG2 cells through activation of caspase-3. Oncology Reports, 18(1), 181-187.
135. Li, Y., Zhang, T., Korkaya, H., Liu, S., Lee, H. F., Newman, B., et al. (2010). Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clinical Cancer Research, 16(9), 2580-2590.
136. Guyton, K. Z., Kensler, T. W., & Posner, G. H. (2001). Cancer chemoprevention using natural vitamin D and synthetic analogs. Annual Review of Pharmacology and Toxicology, 41(1), 421-442.
137. Hope, C., Planutis, K., Planutiene, M., Moyer, M. P., Johal, K. S., Woo, J., et al. (2008). Low concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: implications for colon cancer prevention. Molecular Nutrition & Food Research, 52(Suppl 1), S52-S61.
138. Roccaro, A. M., Leleu, X., Sacco, A., Moreau, A. S., Hatjiharissi, E., Jia, X., et al. (2008). Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenstrom's macroglobulinemia. Clinical Cancer Research, 14(6), 1849-1858.
139. Li, Y., Wang, Z., Kong, D., Murthy, S., Dou, Q. P., Sheng, S., et al. (2007). Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3′-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. Journal of Biological Chemistry, 282(29), 21542-21550.
140. Ding, X. Y., Ding, J., Wu, K., Wen, W., Liu, C., Yan, H. X., et al. (2012). Cross-talk between endothelial cells and tumor via delta-like ligand 4/Notch/PTEN signaling inhibits lung cancer growth. Oncogene, 31(23), 2899-2906.
141. Wang, Z., Li, Y., Banerjee, S., & Sarkar, F. H. (2009). Emerging role of Notch in stem cells and cancer. Cancer Letters, 279(1), 8-12.
142. Farnie, G., & Clarke, R. B. (2007). Mammary stem cells and breast cancer - role of Notch signalling. Stem Cell Reviews, 3(2), 169-175.
143. van Es, J. H., van Gijn, M. E., Riccio, O., van den Born, M., Vooijs, M., Begthel, H., et al. (2005). Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature, 435(7044), 959-963.
144. Chen, Y., Shu, W., Chen, W., Wu, Q., Liu, H., & Cui, G. (2007). Curcumin, both histone deacetylase and p300/CBP-specific inhibitor, represses the activity of nuclear factor kappa B and Notch 1 in Raji cells. Basic and Clinical Pharmacology and Toxicology, 101(6), 427-433.
145. Wang, J., Shelly, L., Miele, L., Boykins, R., Norcross, M. A., & Guan, E. (2001). Human Notch-1 inhibits NF-kappa B activity in the nucleus through a direct interaction involving a novel domain. Journal of Immunology, 167(1), 289-295.
146. Cheng, P., Zlobin, A., Volgina, V., Gottipati, S., Osborne, B., Simel, E.
147. Katoh, M. (2007). Notch signaling in gastrointestinal tract (review). International Journal of Oncology, 30(1), 247-251.
148. Chen, X., Stoeck, A., Lee, S. J., Shih Ie, M., Wang, M. M., & Wang, T. L. (2010). Jagged1 expression regulated by Notch3 and Wnt/beta-catenin signaling pathways in ovarian cancer. Oncotarget, 1(3), 210-218.
149. Pancewicz, J., Taylor, J. M., Datta, A., Baydoun, H. H., Waldmann, T. A., Hermine, O., et al. (2010). Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia. Proceedings of the National Academy of Sciences of the United States of America, 107(38), 16619-16624.
150. Duncan, A. W., Rattis, F. M., DiMascio, L. N., Congdon, K. L., Pazianos, G., Zhao, C., et al. (2005). Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nature Immunology, 6(3), 314-322.
151. Cecchinato, V., Chiaramonte, R., Nizzardo, M., Cristofaro, B., Basile, A., Sherbet, G. V., et al. (2007). Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells. Biochemical Pharmacology, 74(11), 1568-1574.
152. Li, Y., Zhang, J., Ma, D., Zhang, L., Si, M., Yin, H., et al. (2012). Curcumin inhibits proliferation and invasion of osteosarcoma cells through inactivation of Notch-1 signaling. FEBS Journal, 279(12), 2247-2259.
153. Liao, S., Xia, J., Chen, Z., Zhang, S., Ahmad, A., Miele, L., et al. (2011). Inhibitory effect of curcumin on oral carcinoma CAL-27 cells via suppression of Notch-1 and NF-kappaB signaling pathways. Journal of Cellular Biochemistry, 112(4), 1055-1065.
154. Ponnurangam, S., Mammen, J. M., Ramalingam, S., He, Z., Zhang, Y., Umar, S., et al. (2012). Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells. Molecular Cancer Therapeutics, 11(4), 963-972.
155. Pan, H., Zhou, W., He, W., Liu, X., Ding, Q., Ling, L., et al. (2012). Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-kappaB activity via the Notch-1 pathway. International Journal of Molecular Medicine, 30(2), 337-343.
156. Liu, X., Zhang, D. Y., Zhang, W., Zhao, X., Yuan, C., & Ye, F. (2011). The effect of green tea extract and EGCG on the signaling network in squamous cell carcinoma. Nutrition and Cancer, 63(3), 466-475.
157. Hahm, E.-R., Chandra-Kuntal, K., Desai, D., Amin, S., & Singh, S. V. (2012). Notch activation is dispensable for D,L-sulforaphane-mediated inhibition of human prostate cancer cell migration. PLoS One, 7(9), e44957.
158. Wang, Z., Zhang, Y., Banerjee, S., Li, Y., & Sarkar, F. H. (2006). Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer, 106(11), 2503-2513.
159. Harikumar, K. B., & Aggarwal, B. B. (2008). Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle, 7(8), 1020-1035.
160. Aggarwal, B. B., Bhardwaj, A., Aggarwal, R. S., Seeram, N. P., Shishodia, S., & Takada, Y. (2004). Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Research, 24(5A), 2783-2840.
161. Lin, H., Xiong, W., Zhang, X., Liu, B., Zhang, W., Zhang, Y., et al. (2011). Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells. Oncology Reports, 26(4), 925-930.
162. Wang, Q., Li, H., Liu, N., Chen, X. Y., Wu, M. L., Zhang, K. L., et al. (2008). Correlative analyses of notch signaling with resveratrol-induced differentiation and apoptosis of human medulloblastoma cells. Neuroscience Letters, 438(2), 168-173.
163. Truong, M., Cook, M. R., Pinchot, S. N., Kunnimalaiyaan, M., & Chen, H. (2011). Resveratrol induces Notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer. Annals of Surgical Oncology, 18(5), 1506-1511.
164. Pinchot, S. N., Jaskula-Sztul, R., Ning, L., Peters, N. R., Cook, M. R., Kunnimalaiyaan, M., et al. (2011). Identification and validation of Notch pathway activating compounds through a novel high-throughput screening method. Cancer, 117(7), 1386-1398.
165. Barnes, S. (1995). Effect of genistein on in vitro and in vivo models of cancer. Journal of Nutrition, 125(3 Suppl), 777S-783S.
166. Wang, Z., Zhang, Y., Li, Y., Banerjee, S., Liao, J., & Sarkar, F. H. (2006). Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Molecular Cancer Therapeutics, 5(3), 483-493.
167. Janardhanan, R., Banik, N. L., & Ray, S. K. (2009). N-Myc down regulation induced differentiation, early cell cycle exit, and apoptosis in human malignant neuroblastoma cells having wild type or mutant p53. Biochemical Pharmacology, 78(9), 1105-1114.
168. Singh, B. N., Fu, J., Srivastava, R. K., & Shankar, S. (2011). Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms. PLoS One, 6(11), e27306.
169. Hooper, J. E., & Scott, M. P. (2005). Communicating with Hedgehogs. Nature Reviews Molecular Cell Biology, 6(4), 306-317.
170. Zhang, Y., & Kalderon, D. (2001). Hedgehog acts as a somatic stem cell factor in the Drosophila ovary. Nature, 410(6828), 599-604.
171. Taipale, J., & Beachy, P. A. (2001). The Hedgehog and Wnt signalling pathways in cancer. Nature, 411(6835), 349-354.
172. Xu, M., Li, X., Liu, T., Leng, A., & Zhang, G. (2012). Prognostic value of hedgehog signaling pathway in patients with colon cancer. Medical Oncology, 29(2), 1010-1016.
173. Agyeman, A., Mazumdar, T., & Houghton, J. A. (2012). Regulation of DNA damage following termination of hedgehog (HH) survival signaling at the level of the GLI genes in human colon cancer. Oncotarget, 3(8), 854-868.
174. Harris, L. G., Pannell, L. K., Singh, S., Samant, R. S., & Shevde, L. A. (2012). Increased vascularity and spontaneous metastasis of breast cancer by hedgehog signaling mediated upregulation of cyr61. Oncogene, 31(28), 3370-3380.
175. Ji, H., Miao, J., Zhang, X., Du, Y., Liu, H., Li, S., et al. (2012). Inhibition of Sonic hedgehog signaling aggravates brain damage associated with the down-regulation of Gli1, Ptch1 and SOD1 expression in acute ischemic stroke. Neuroscience Letters, 506(1), 1-6.
176. Rohner, A., Spilker, M. E., Lam, J. L., Pascual, B., Bartkowski, D., Li, Q. J., et al. (2012). Effective targeting of Hedgehog signaling in a medulloblastoma model with PF-5274857, a potent and selective Smoothened antagonist that penetrates the blood-brain barrier. Molecular Cancer Therapeutics, 11(1), 57-65.
177. Yang, L., Wang, L. S., Chen, X. L., Gatalica, Z., Qiu, S., Liu, Z., et al. (2012). Hedgehog signaling activation in the development of squamous cell carcinoma and adenocarcinoma of esophagus. International Journal of Biochemistry and Molecular Biology, 3(1), 46-57.
178. Kappler, R., & von Schweinitz, D. (2012). A better way forward: targeting hedgehog signaling in liver cancer. Frontiers in Bioscience (Scholar Edition), 4, 277-286.
179. Ray, A., Meng, E., Reed, E., Shevde, L. A., & Rocconi, R. P. (2011). Hedgehog signaling pathway regulates the growth of ovarian cancer spheroid forming cells. International Journal of Oncology, 39(4), 797-804.
180. McCann, C. K., Growdon, W. B., Kulkarni-Datar, K., Curley, M. D., Friel, A. M., Proctor, J. L., et al. (2011). Inhibition of Hedgehog signaling antagonizes serous ovarian cancer growth in a primary xenograft model. PLoS One, 6(11), e28077.
181. Clement, V., Sanchez, P., de Tribolet, N., Radovanovic, I., & Ruiz i Altaba, A. (2007). HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Current Biology, 17(2), 165-172.
182. Mazumdar, T., DeVecchio, J., Shi, T., Jones, J., Agyeman, A., & Houghton, J. A. (2011). Hedgehog signaling drives cellular survival in human colon carcinoma cells. Cancer Research, 71(3), 1092-1102.
183. Kanda, S., Mochizuki, Y., Suematsu, T., Miyata, Y., Nomata, K., & Kanetake, H. (2003). Sonic hedgehog induces capillary morphogenesis by endothelial cells through phosphoinositide 3-kinase. Journal of Biological Chemistry, 278(10), 8244-8249.
184. Varjosalo, M., & Taipale, J. (2007). Hedgehog signaling. Journal of Cell Science, 120(Pt 1), 3-6.
185. Peacock, C. D., Wang, Q., Gesell, G. S., Corcoran-Schwartz, I. M., Jones, E., Kim, J., et al. (2007). Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proceedings of the National Academy of Sciences of the United States of America, 104(10), 4048-4053.
186. Chen, J. K., Taipale, J., Cooper, M. K., & Beachy, P. A. (2002). Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes and Development, 16(21), 2743-2748.
187. Tang, S. N., Fu, J., Nall, D., Rodova, M., Shankar, S., & Srivastava, R. K. (2012). Inhibition of Sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics. International Journal of Cancer, 131(1), 30-40.
188. Elamin, M. H., Shinwari, Z., Hendrayani, S. F., Al-Hindi, H., Al-Shail, E., Khafaga, Y., et al. (2010). Curcumin inhibits the Sonic hedgehog signaling pathway and triggers apoptosis in medulloblastoma cells. Molecular Carcinogenesis, 49(3), 302-314.
189. Liao, H. F., Su, Y. C., Zheng, Z. Y., Jhih Cai, C., Hou, M. H., Chao, K. S., et al. (2012). Sonic hedgehog signaling regulates Bcr-Abl expression in human chronic myeloid leukemia cells. Biomedicine and Pharmacotherapy, 66(5), 378-383.
190. Mo, W., Xu, X., Xu, L., Wang, F., Ke, A., Wang, X., et al. (2011). Resveratrol inhibits proliferation and induces apoptosis through the hedgehog signaling pathway in pancreatic cancer cell. Pancreatology, 11(6), 601-609.
191. Li, Y., Maitah, M. Y., Ahmad, A., Kong, D., Bao, B., & Sarkar, F. H. (2012). Targeting the Hedgehog signaling pathway for cancer therapy. Expert Opinion on Therapeutic Targets, 16(1), 49-66.
192. Slusarz, A., Shenouda, N. S., Sakla, M. S., Drenkhahn, S. K., Narula, A. S., MacDonald, R. S., et al. (2010). Common botanical compounds inhibit the hedgehog signaling pathway in prostate cancer. Cancer Research, 70(8), 3382-3390.
193. Kawasaki, B. T., Hurt, E. M., Mistree, T., & Farrar, W. L. (2008). Targeting cancer stem cells with phytochemicals. Molecular Interventions, 8(4), 174-184.
194. Berman, D. M., Karhadkar, S. S., Hallahan, A. R., Pritchard, J. I., Eberhart, C. G., Watkins, D. N., et al. (2002). Medulloblastoma growth inhibition by hedgehog pathway blockade. Science, 297(5586), 1559-1561.
195. Feldmann, G., Dhara, S., Fendrich, V., Bedja, D., Beaty, R., Mullendore, M., et al. (2007). Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Research, 67(5), 2187-2196.
196. Chitkara, D., Singh, S., Kumar, V., Danquah, M., Behrman, S. W., Kumar, N., et al. (2012). Micellar delivery of cyclopamine and gefitinib for treating pancreatic cancer. Molecular Pharmaceutics, 9(8), 2350-2357.
197. Wang, Y., Li, M., Xu, X., Song, M., Tao, H., & Bai, Y. (2012). Green tea epigallocatechin-3-gallate (EGCG) promotes neural progenitor cell proliferation and Sonic hedgehog pathway activation during adult hippocampal neurogenesis. Molecular Nutrition & Food Research, 56(8), 1292-1303.
198. Zhang, L., Li, L., Jiao, M., Wu, D., Wu, K., Li, X., et al. (2012). Genistein inhibits the stemness properties of prostate cancer cells through targeting Hedgehog-Gli1 pathway. Cancer Letters, 323(1), 48-57.
199. Rawlings, J. S., Rosler, K. M., & Harrison, D. A. (2004). The JAK/STAT signaling pathway. Journal of Cell Science, 117(Pt 8), 1281-1283.
200. Ozawa, Y., Williams, A. H., Estes, M. L., Matsushita, N., Boschelli, F., Jove, R., et al. (2008). Src family kinases promote AML cell survival through activation of signal transducers and activators of transcription (STAT). Leukemia Research, 32(6), 893-903.
201. Aaronson, D. S., & Horvath, C. M. (2002). A road map for those who don't know JAK-STAT. Science, 296(5573), 1653-1655.
202. Kwon, E. M., Holt, S. K., Fu, R., Kolb, S., Williams, G., Stanford, J. L., et al. (2012). Androgen metabolism and JAK/STAT pathway genes and prostate cancer risk. Cancer Epidemiology, 36(4), 347-353.
203. Qin, Y., He, L. Y., Chen, Y., Wang, W. Y., Zhao, X. H., & Wu, M. Y. (2012). Quercetin affects leptin and its receptor in human gastric cancer MGC-803 cells and JAK-STAT pathway. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 28(1), 12-16.
204. Uluer, E. T., Aydemir, I., Inan, S., Ozbilgin, K., & Vatansever, H. S. (2012). Effects of 5-fluorouracil and gemcitabine on a breast cancer cell line (MCF-7) via the JAK/STAT pathway. Acta Histochemica, 114(7), 641-646.
205. Masamune, A., Satoh, M., Kikuta, K., Suzuki, N., & Shimosegawa, T. (2005). Activation of JAK-STAT pathway is required for platelet-derived growth factor-induced proliferation of pancreatic stellate cells. World Journal of Gastroenterology, 11(22), 3385-3391.
206. Slattery, M. L., Lundgreen, A., Kadlubar, S. A., Bondurant, K. L., & Wolff, R. K. (2011). JAK/STAT/SOCS-signaling pathway and colon and rectal cancer. Molecular Carcinogenesis, 52(2), 155-166.
207. Kacimi, R., Giffard, R. G., & Yenari, M. A. (2011). Endotoxin-activated microglia injure brain derived endothelial cells via NF-kappaB, JAK-STAT and JNK stress kinase pathways. Journal of Inflammation (London), 8, 7.
208. Kiger, A. A., Jones, D. L., Schulz, C., Rogers, M. B., & Fuller, M. T. (2001). Stem cell self-renewal specified by JAK-STAT activation in response to a support cell cue. Science, 294(5551), 2542-2545.
209. Madan, E., Prasad, S., Roy, P., George, J., & Shukla, Y. (2008). Regulation of apoptosis by resveratrol through JAK/STAT and mitochondria mediated pathway in human epidermoid carcinoma A431 cells. Biochemical and Biophysical Research Communications, 377(4), 1232-1237.
210. Wang, W. Z., Zhang, B. Y., Yuan, J., Mao, J. W., & Mei, W. J. (2009). Effect of curcumin on JAK-STAT signaling pathway in hepatoma cell lines. Yao Xue Xue Bao, 44(12), 1434-1439.
211. Rajasingh, J., Raikwar, H. P., Muthian, G., Johnson, C., & Bright, J. J. (2006). Curcumin induces growth-arrest and apoptosis in association with the inhibition of constitutively active JAK-STAT pathway in T cell leukemia. Biochemical and Biophysical Research Communications, 340(2), 359-368.
212. Shin, D. S., Kim, H. N., Shin, K. D., Yoon, Y. J., Kim, S. J., Han, D. C., et al. (2009). Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells. Cancer Research, 69(1), 193-202.
213. Liu, J. (1995). Pharmacology of oleanolic acid and ursolic acid. Journal of Ethnopharmacology, 49(2), 57-68.
214. Shanmugam, M. K., Rajendran, P., Li, F., Nema, T., Vali, S., Abbasi, T., et al. (2011). Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice. Journal of Molecular Medicine (Berlin), 89(7), 713-727.
215. Hoernlein, R. F., Orlikowsky, T., Zehrer, C., Niethammer, D., Sailer, E. R., Simmet, T., et al. (1999). Acetyl-11-keto-beta-boswellic acid induces apoptosis in HL-60 and CCRF-CEM cells and inhibits topoisomerase I. Journal of Pharmacology and Experimental Therapeutics, 288(2), 613-619.
216. Sun, J., Blaskovich, M. A., Jove, R., Livingston, S. K., Coppola, D., & Sebti, S. M. (2005). Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity. Oncogene, 24(20), 3236-3245.
217. Li, F., Rajendran, P., & Sethi, G. (2010). Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathway. British Journal of Pharmacology, 161(3), 541-554.
218. Tedeschi, E., Suzuki, H., & Menegazzi, M. (2002). Antiinflammatory action of EGCG, the main component of green tea, through STAT-1 inhibition. Annals of the New York Academy of Sciences, 973, 435-437.
219. Tang, S. N., Fu, J., Shankar, S., & Srivastava, R. K. (2012). EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer. PLoS One, 7(2), e31067.
220. Trecul, A., Morceau, F., Dicato, M., & Diederich, M. (2012). Dietary compounds as potent inhibitors of the signal transducers and activators of transcription (STAT) 3 regulatory network. Genes and Nutrition, 7(2), 111-125.
221. Tan, S. M., Li, F., Rajendran, P., Kumar, A. P., Hui, K. M., & Sethi, G. (2010). Identification of beta-escin as a novel inhibitor of signal transducer and activator of transcription 3/Janus-activated kinase 2 signaling pathway that suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells. Journal of Pharmacology and Experimental Therapeutics, 334(1), 285-293.
222. Bhutani, M., Pathak, A. K., Nair, A. S., Kunnumakkara, A. B., Guha, S., Sethi, G., et al. (2007). Capsaicin is a novel blocker of constitutive and interleukin-6-inducible STAT3 activation. Clinical Cancer Research, 13(10), 3024-3032.
223. Nelson, D. M., Joseph, B., Hillion, J., Segal, J., Karp, J. E., & Resar, L. M. (2011). Flavopiridol induces BCL-2 expression and represses oncogenic transcription factors in leukemic blasts from adults with refractory acute myeloid leukemia. Leukemia and Lymphoma, 52(10), 1999-2006.
224. Syed, D. N., Afaq, F., Sarfaraz, S., Khan, N., Kedlaya, R., Setaluri, V., et al. (2008). Delphinidin inhibits cell proliferation and invasion via modulation of Met receptor phosphorylation. Toxicology and Applied Pharmacology, 231(1), 52-60.
225. Kannaiyan, R., Hay, H. S., Rajendran, P., Li, F., Shanmugam, M. K., Vali, S., et al. (2011). Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-kappaB and STAT3 regulated gene products in multiple myeloma cells. British Journal of Pharmacology, 164(5), 1506-1521.
226. Rajendran, P., Ong, T. H., Chen, L., Li, F., Shanmugam, M. K., Vali, S., et al. (2011). Suppression of signal transducer and activator of transcription 3 activation by butein inhibits growth of human hepatocellular carcinoma in vivo. Clinical Cancer Research, 17(6), 1425-1439.
227. Rajendran, P., Li, F., Manu, K. A., Shanmugam, M. K., Loo, S. Y., Kumar, A. P., et al. (2011). gamma-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent. British Journal of Pharmacology, 163(2), 283-298.
228. Li, F., Fernandez, P. P., Rajendran, P., Hui, K. M., & Sethi, G. (2010). Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells. Cancer Letters, 292(2), 197-207.
229. Wung, B. S., Hsu, M. C., Wu, C. C., & Hsieh, C. W. (2005). Resveratrol suppresses IL-6-induced ICAM-1 gene expression in endothelial cells: effects on the inhibition of STAT3 phosphorylation. Life Sciences, 78(4), 389-397.
230. Schnyder, B., Schnyder-Candrian, S., Panski, A., Bommel, H., Heim, M., Duschl, A., et al. (2002). Phytochemical inhibition of interleukin-4-activated Stat6 and expression of VCAM-1. Biochemical and Biophysical Research Communications, 292(4), 841-847.
231. Pandey, M. K., Sung, B., Ahn, K. S., & Aggarwal, B. B. (2009). Butein suppresses constitutive and inducible signal transducer and activator of transcription (STAT) 3 activation and STAT3-regulated gene products through the induction of a protein tyrosine phosphatase SHP-1. Molecular Pharmacology, 75(3), 525-533.
232. Tedeschi, E., Menegazzi, M., Yao, Y., Suzuki, H., Forstermann, U., & Kleinert, H. (2004). Green tea inhibits human inducible nitric-oxide synthase expression by down-regulating signal transducer and activator of transcription-1alpha activation. Molecular Pharmacology, 65(1), 111-120.
233. Masuda, M., Suzui, M., & Weinstein, I. B. (2001). Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clinical Cancer Research, 7(12), 4220-4229.
234. Masuda, M., Suzui, M., Lim, J. T., Deguchi, A., Soh, J. W., & Weinstein, I. B. (2002). Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. Journal of Experimental Therapeutics and Oncology, 2(6), 350-359.
235. Bharti, A. C., Donato, N., & Aggarwal, B. B. (2003). Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. Journal of Immunology, 171(7), 3863-3871.
236. LoPiccolo, J., Blumenthal, G. M., Bernstein, W. B., & Dennis, P. A. (2008). Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations. Drug Resistance Updates, 11(1-2), 32-50.
237. Meydan, N., Grunberger, T., Dadi, H., Shahar, M., Arpaia, E., Lapidot, Z., et al. (1996). Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature, 379(6566), 645-648.
238. Blasius, R., Reuter, S., Henry, E., Dicato, M., & Diederich, M. (2006). Curcumin regulates signal transducer and activator of transcription (STAT) expression in K562 cells. Biochemical Pharmacology, 72(11), 1547-1554.
239. Syrovets, T., Gschwend, J. E., Buchele, B., Laumonnier, Y., Zugmaier, W., Genze, F., et al. (2005). Inhibition of IkappaB kinase activity by acetyl-boswellic acids promotes apoptosis in androgen-independent PC-3 prostate cancer cells in vitro and in vivo. Journal of Biological Chemistry, 280(7), 6170-6180.
240. Vivanco, I., & Sawyers, C. L. (2002). The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nature Reviews Cancer, 2(7), 489-501.
241. Leleu, X., Jia, X., Runnels, J., Ngo, H. T., Moreau, A. S., Farag, M., et al. (2007). The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia. Blood, 110(13), 4417-4426.
242. Maira, S. M., Furet, P., & Stauffer, F. (2009). Discovery of novel anticancer therapeutics targeting the PI3K/Akt/mTOR pathway. Future Medicinal Chemistry, 1(1), 137-155.
243. Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., et al. (1999). Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell, 96(6), 857-868.
244. Alessi, D. R., Andjelkovic, M., Caudwell, B., Cron, P., Morrice, N., Cohen, P., et al. (1996). Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO Journal, 15(23), 6541-6551.
245. Hennessy, B. T., Smith, D. L., Ram, P. T., Lu, Y., & Mills, G. B. (2005). Exploiting the PI3K/AKT pathway for cancer drug discovery. Nature Reviews Drug Discovery, 4(12), 988-1004.
246. Beevers, C. S., Li, F., Liu, L., & Huang, S. (2006). Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells. International Journal of Cancer, 119(4), 757-764.
247. Hara, K., Maruki, Y., Long, X., Yoshino, K., Oshiro, N., Hidayat, S., et al. (2002). Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell, 110(2), 177-189.
248. Tang, F. Y., Nguyen, N., & Meydani, M. (2003). Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule. International Journal of Cancer, 106(6), 871-878.
249. Jiang, H., Shang, X., Wu, H., Gautam, S. C., Al-Holou, S., Li, C., et al. (2009). Resveratrol downregulates PI3K/Akt/mTOR signaling pathways in human U251 glioma cells. Journal of Experimental Therapeutics and Oncology, 8(1), 25-33.
250. Li, Y., & Sarkar, F. H. (2002). Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway. Clinical Cancer Research, 8(7), 2369-2377.
251. Chinni, S. R., & Sarkar, F. H. (2002). Akt inactivation is a key event in indole-3-carbinol-induced apoptosis in PC-3 cells. Clinical Cancer Research, 8(4), 1228-1236.
252. Shishodia, S., & Aggarwal, B. B. (2006). Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, I kappa B kinase activation and NF-kappa B-regulated gene expression. Oncogene, 25(10), 1463-1473.
253. Adhami, V. M., Syed, D. N., Khan, N., & Mukhtar, H. (2012). Dietary flavonoid fisetin: a novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management. Biochem Pharmacol, 84(10), 1277-1281.
254. Chen, P. N., Hsieh, Y. S., Chiou, H. L., & Chu, S. C. (2005). Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways. Chemico-Biological Interactions, 156(2-3), 141-150.
255. Aggarwal, S., Ichikawa, H., Takada, Y., Sandur, S. K., Shishodia, S., & Aggarwal, B. B. (2006). Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Molecular Pharmacology, 69(1), 195-206.
256. Binion, D. G., Heidemann, J., Li, M. S., Nelson, V. M., Otterson, M. F., & Rafiee, P. (2009). Vascular cell adhesion molecule-1 expression in human intestinal microvascular endothelial cells is regulated by PI 3-kinase/Akt/MAPK/NF-kappaB: inhibitory role of curcumin. American Journal of Physiology - Gastrointestinal and Liver Physiology, 297(2), G259-G268.
257. Huang, C., Li, J., Song, L., Zhang, D., Tong, Q., Ding, M., et al. (2006). Black raspberry extracts inhibit benzo(a)pyrene diol-epoxide-induced activator protein 1 activation and VEGF transcription by targeting the phosphotidylinositol 3-kinase/Akt pathway. Cancer Research, 66(1), 581-587.
258. Liu, D., Li, P., Song, S., Liu, Y., Wang, Q., Chang, Y., et al. (2012). Pro-apoptotic effect of Epigallo-catechin-3-gallate on B lymphocytes through regulating BAFF/PI3K/Akt/mTOR signaling in rats with collagen-induced arthritis. European Journal of Pharmacology, 690(1-3), 214-225.
259. Peairs, A., Dai, R., Gan, L., Shimp, S., Rylander, M. N., Li, L., et al. (2010). Epigallocatechin-3-gallate (EGCG) attenuates inflammation in MRL/lpr mouse mesangial cells. Cellular and Molecular Immunology, 7(2), 123-132.
260. Adhami, V. M., Siddiqui, I. A., Ahmad, N., Gupta, S., & Mukhtar, H. (2004). Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Research, 64(23), 8715-8722.
261. Syed, D. N., Afaq, F., Kweon, M. H., Hadi, N., Bhatia, N., Spiegelman, V. S., et al. (2007). Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappaB activation in normal human bronchial epithelial cells. Oncogene, 26(5), 673-682.
262. Siddiqui, I. A., Adhami, V. M., Afaq, F., Ahmad, N., & Mukhtar, H. (2004). Modulation of phosphatidylinositol-3-kinase/protein kinase B- and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells. Journal of Cellular Biochemistry, 91(2), 232-242.
263. Li, H. L., Huang, Y., Zhang, C. N., Liu, G., Wei, Y. S., Wang, A. B., et al. (2006). Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways. Free Radical Biology and Medicine, 40(10), 1756-1775.
264. Squires, M. S., Hudson, E. A., Howells, L., Sale, S., Houghton, C. E., Jones, J. L., et al. (2003). Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells. Biochemical Pharmacology, 65(3), 361-376.
265. Chaudhary, L. R., & Hruska, K. A. (2003). Inhibition of cell survival signal protein kinase B/Akt by curcumin in human prostate cancer cells. Journal of Cellular Biochemistry, 89(1), 1-5.
266. Li, M., Zhang, Z., Hill, D. L., Wang, H., & Zhang, R. (2007). Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway. Cancer Research, 67(5), 1988-1996.
267. Brito, P. M., Devillard, R., Negre-Salvayre, A., Almeida, L. M., Dinis, T. C., Salvayre, R., et al. (2009). Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells. Atherosclerosis, 205(1), 126-134.
268. Garcia-Maceira, P., & Mateo, J. (2009). Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy. Oncogene, 28(3), 313-324.
269. Yi, T., Cho, S. G., Yi, Z., Pang, X., Rodriguez, M., Wang, Y., et al. (2008). Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways. Molecular Cancer Therapeutics, 7(7), 1789-1796.
270. Anderson, M. J., Viars, C. S., Czekay, S., Cavenee, W. K., & Arden, K. C. (1998). Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily. Genomics, 47(2), 187-199.
271. Glauser, D. A., & Schlegel, W. (2007). The emerging role of FOXO transcription factors in pancreatic beta cells. Journal of Endocrinology, 193(2), 195-207.
272. Myatt, S. S., & Lam, E. W. (2007). The emerging roles of forkhead box (Fox) proteins in cancer. Nature Reviews Cancer, 7(11), 847-859.
273. Ekoff, M., Kaufmann, T., Engstrom, M., Motoyama, N., Villunger, A., Jonsson, J. I., et al. (2007). The BH3-only protein Puma plays an essential role in cytokine deprivation induced apoptosis of mast cells. Blood, 110(9), 3209-3217.
274. Skurk, C., Maatz, H., Kim, H. S., Yang, J., Abid, M. R., Aird, W. C., et al. (2004). The Akt-regulated forkhead transcription factor FOXO3a controls endothelial cell viability through modulation of the caspase-8 inhibitor FLIP. Journal of Biological Chemistry, 279(2), 1513-1525.
275. Chen, Q., Ganapathy, S., Singh, K. P., Shankar, S., & Srivastava, R. K. (2010). Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells. PLoS One, 5(12), e15288.
276. Xiao, D., Bommareddy, A., Kim, S. H., Sehrawat, A., Hahm, E. R., & Singh, S. V. (2012). Benzyl isothiocyanate causes FoxO1-mediated autophagic death in human breast cancer cells. PLoS One, 7(3), e32597.
277. Ross, A. E., Marchionni, L., Phillips, T. M., Miller, R. M., Hurley, P. J., Simons, B. W., et al. (2011). Molecular effects of genistein on male urethral development. Journal of Urology, 185(5), 1894-1898.
278. Shankar, S., Marsh, L., & Srivastava, R. K. (2012). EGCG inhibits growth of human pancreatic tumors orthotopically implanted in Balb C nude mice through modulation of FKHRL1/FOXO3a and neuropilin. Molecular and Cellular Biochemistry, 372(1-2), 83-94.
279. Bartholome, A., Kampkotter, A., Tanner, S., Sies, H., & Klotz, L. O. (2010). Epigallocatechin gallate-induced modulation of FoxO signaling in mammalian cells and C. elegans: FoxO stimulation is masked via PI3K/Akt activation by hydrogen peroxide formed in cell culture. Archives of Biochemistry and Biophysics, 501(1), 58-64.
280. Roy, S. K., Chen, Q., Fu, J., Shankar, S., & Srivastava, R. K. (2011). Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors. PLoS One, 6(9), e25166.
281. Ganapathy, S., Chen, Q., Singh, K. P., Shankar, S., & Srivastava, R. K. (2010). Resveratrol enhances antitumor activity of TRAIL in prostate cancer xenografts through activation of FOXO transcription factor. PLoS One, 5(12), e15627.
282. Shankar, S., Chen, Q., & Srivastava, R. K. (2008). Inhibition of PI3K/AKT and MEK/ERK pathways act synergistically to enhance antiangiogenic effects of EGCG through activation of FOXO transcription factor. Journal of Molecular Signaling, 3, 7.
283. Downward, J. (2003). Targeting RAS signalling pathways in cancer therapy. Nature Reviews Cancer, 3(1), 11-22.
284. Sebolt-Leopold, J. S. (2000). Development of anticancer drugs targeting the MAP kinase pathway. Oncogene, 19(56), 6594-6599.
285. Bode, A. M., & Dong, Z. (2003). Mitogen-activated protein kinase activation in UV-induced signal transduction. Science's STKE, 2003(167), RE2.
286. Sarkar, F. H., & Li, Y. (2006). Using chemopreventive agents to enhance the efficacy of cancer therapy. Cancer Research, 66(7), 3347-3350.
287. Cho, J. W., Park, K., Kweon, G. R., Jang, B. C., Baek, W. K., Suh, M. H., et al. (2005). Curcumin inhibits the expression of COX-2 in UVB-irradiated human keratinocytes (HaCaT) by inhibiting activation of AP-1: p38 MAP kinase and JNK as potential upstream targets. Experimental and Molecular Medicine, 37(3), 186-192.
288. Klawitter, M., Quero, L., Klasen, J., Gloess, A., Klopprogge, B., Hausmann, O., et al. (2012). Curcuma DMSO extracts and curcumin exhibit an anti-inflammatory and anti-catabolic effect on human intervertebral disc cells, possibly by influencing TLR2 expression and JNK activity. Journal of Inflammation (London), 9(1), 29.
289. Chen, C., Shen, G., Hebbar, V., Hu, R., Owuor, E. D., & Kong, A. N. (2003). Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells. Carcinogenesis, 24(8), 1369-1378.
290. Li, Y., Li, X., & Sarkar, F. H. (2003). Gene expression profiles of I3C- and DIM-treated PC3 human prostate cancer cells determined by cDNA microarray analysis. Journal of Nutrition, 133(4), 1011-1019.
291. Yu, R., Lei, W., Mandlekar, S., Weber, M. J., Der, C. J., Wu, J., et al. (1999). Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals. Journal of Biological Chemistry, 274(39), 27545-27552.
292. Aggarwal, B. B., Kunnumakkara, A. B., Harikumar, K. B., Tharakan, S. T., Sung, B., & Anand, P. (2008). Potential of spice-derived phytochemicals for cancer prevention. Planta Medica, 74(13), 1560-1569.
293. Ye, F., Zhang, G. H., Guan, B. X., & Xu, X. C. (2012). Suppression of esophageal cancer cell growth using curcumin, (-)-epigallocatechin-3-gallate and lovastatin. World Journal of Gastroenterology, 18(2), 126-135.
294. Katiyar, S. K., Afaq, F., Azizuddin, K., & Mukhtar, H. (2001). Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatechin-3-gallate. Toxicology and Applied Pharmacology, 176(2), 110-117.
295. Keum, Y. S., Owuor, E. D., Kim, B. R., Hu, R., & Kong, A. N. (2003). Involvement of Nrf2 and JNK1 in the activation of antioxidant responsive element (ARE) by chemopreventive agent phenethyl isothiocyanate (PEITC). Pharmaceutical Research, 20(9), 1351-1356.
296. Salh, B., Assi, K., Templeman, V., Parhar, K., Owen, D., Gomez-Munoz, A., et al. (2003). Curcumin attenuates DNB-induced murine colitis. American Journal of Physiology - Gastrointestinal and Liver Physiology, 285(1), G235-G243.
297. Yang, C. W., Chang, C. L., Lee, H. C., Chi, C. W., Pan, J. P., & Yang, W. C. (2012). Curcumin induces the apoptosis of human monocytic leukemia THP-1 cells via the activation of JNK/ERK pathways. BMC Complementary and Alternative Medicine, 12, 22.
298. Chen, Y. R., & Tan, T. H. (1998). Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene, 17(2), 173-178.
299. Chen, C., Yu, R., Owuor, E. D., & Kong, A. N. (2000). Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Archives of Pharmacal Research, 23(6), 605-612.
300. Deguchi, H., Fujii, T., Nakagawa, S., Koga, T., & Shirouzu, K. (2002). Analysis of cell growth inhibitory effects of catechin through MAPK in human breast cancer cell line T47D. International Journal of Oncology, 21(6), 1301-1305.
301. Yu, R., Jiao, J. J., Duh, J. L., Gudehithlu, K., Tan, T. H., & Kong, A. N. (1997). Activation of mitogen-activated protein kinases by green tea polyphenols: potential signaling pathways in the regulation of antioxidant-responsive element-mediated phase II enzyme gene expression. Carcinogenesis, 18(2), 451-456.
302. Maeda-Yamamoto, M., Suzuki, N., Sawai, Y., Miyase, T., Sano, M., Hashimoto-Ohta, A., et al. (2003). Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells. Journal of Agricultural and Food Chemistry, 51(7), 1858-1863.
303. Dong, Z., Ma, W., Huang, C., & Yang, C. S. (1997). Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins. Cancer Research, 57(19), 4414-4419.
304. Agarwal, C., Sharma, Y., Zhao, J., & Agarwal, R. (2000). A polyphenolic fraction from grape seeds causes irreversible growth inhibition of breast carcinoma MDA-MB468 cells by inhibiting mitogen-activated protein kinases activation and inducing G1 arrest and differentiation. Clinical Cancer Research, 6(7), 2921-2930.
305. Sun, Z., & Andersson, R. (2002). NF-[kappa]B Activation and Inhibition: a review. Shock, 18(2), 99-106.
306. Mercurio, F., & Manning, A. M. (1999). Multiple signals converging on NF-kappaB. Current Opinion in Cell Biology, 11(2), 226-232.
307. Kim, J. M., Lee, E. K., Kim, D. H., Yu, B. P., & Chung, H. Y. (2010). Kaempferol modulates pro-inflammatory NF-kappaB activation by suppressing advanced glycation endproducts-induced NADPH oxidase. Age (Dordrecht, Netherlands), 32(2), 197-208.
308. Simone, R. E., Russo, M., Catalano, A., Monego, G., Froehlich, K., Boehm, V., et al. (2011). Lycopene inhibits NF-κB -mediated IL-8 expression and changes redox and PPARgamma signalling in cigarette smoke-stimulated macrophages. PLoS One, 6(5), e19652.
309. Siddiqui, I. A., Shukla, Y., Adhami, V. M., Sarfaraz, S., Asim, M., Hafeez, B. B., et al. (2008). Suppression of NFkappaB and its regulated gene products by oral administration of green tea polyphenols in an autochthonous mouse prostate cancer model. Pharmaceutical Research, 25(9), 2135-2142.
310. Guimaraes, M. R., Coimbra, L. S., de Aquino, S. G., Spolidorio, L. C., Kirkwood, K. L., & Rossa, C., Jr. (2011). Potent anti-inflammatory effects of systemically administered curcumin modulate periodontal disease in vivo. Journal of Periodontal Research, 46(2), 269-279.
311. Yadav, V. R., Prasad, S., Sung, B., & Aggarwal, B. B. (2011). The role of chalcones in suppression of NF-kappaB-mediated inflammation and cancer. International Immunopharmacology, 11(3), 295-309.
312. Takada, Y., Murakami, A., & Aggarwal, B. B. (2005). Zerumbone abolishes NF-kappaB and IkappaBalpha kinase activation leading to suppression of antiapoptotic and metastatic gene expression, upregulation of apoptosis, and downregulation of invasion. Oncogene, 24(46), 6957-6969.
313. Checker, R., Sandur, S. K., Sharma, D., Patwardhan, R. S., Jayakumar, S., Kohli, V., et al. (2012). Potent anti-inflammatory activity of ursolic acid, a triterpenoid antioxidant, is mediated through suppression of NF-kappaB, AP-1 and NF-AT. PLoS One, 7(2), e31318.
314. Xu, L., Zhang, L., Bertucci, A. M., Pope, R. M., & Datta, S. K. (2008). Apigenin, a dietary flavonoid, sensitizes human T cells for activation-induced cell death by inhibiting PKB/Akt and NF-kappaB activation pathway. Immunology Letters, 121(1), 74-83.
315. Lin, H. H., Chen, J. H., Chou, F. P., & Wang, C. J. (2011). Protocatechuic acid inhibits cancer cell metastasis involving the down-regulation of Ras/Akt/NF-kappaB pathway and MMP-2 production by targeting RhoB activation. British Journal of Pharmacology, 162(1), 237-254.
316. Afaq, F., Ahmad, N., & Mukhtar, H. (2003). Suppression of UVB-induced phosphorylation of mitogen-activated protein kinases and nuclear factor kappa B by green tea polyphenol in SKH-1 hairless mice. Oncogene, 22(58), 9254-9264.
317. Ahmad, N., Gupta, S., & Mukhtar, H. (2000). Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells. Archives of Biochemistry and Biophysics, 376(2), 338-346.
318. Takada, Y., & Aggarwal, B. B. (2003). Betulinic acid suppresses carcinogen-induced NF-kappa B activation through inhibition of I kappa B alpha kinase and p65 phosphorylation: abrogation of cyclooxygenase-2 and matrix metalloprotease-9. Journal of Immunology, 171(6), 3278-3286.
319. Kumar, A., Dhawan, S., & Aggarwal, B. B. (1998). Emodin (3-methyl-1,6,8-trihydroxyanthraquinone) inhibits TNF-induced NF-kappaB activation, IkappaB degradation, and expression of cell surface adhesion proteins in human vascular endothelial cells. Oncogene, 17(7), 913-918.
320. Kim, S. O., Chun, K. S., Kundu, J. K., & Surh, Y. J. (2004). Inhibitory effects of [6]-gingerol on PMA-induced COX-2 expression and activation of NF-kappaB and p38 MAPK in mouse skin. Biofactors, 21(1-4), 27-31.
321. Pradeep, C. R., & Kuttan, G. (2004). Piperine is a potent inhibitor of nuclear factor-kappaB (NF-kappaB), c-Fos, CREB, ATF-2 and proinflammatory cytokine gene expression in B16F-10 melanoma cells. International Immunopharmacology, 4(14), 1795-1803.
322. Chainy, G. B., Manna, S. K., Chaturvedi, M. M., & Aggarwal, B. B. (2000). Anethole blocks both early and late cellular responses transduced by tumor necrosis factor: effect on NF-kappaB, AP-1, JNK, MAPKK and apoptosis. Oncogene, 19(25), 2943-2950.
323. Geng, Z., Rong, Y., & Lau, B. H. (1997). S-allyl cysteine inhibits activation of nuclear factor kappa B in human T cells. Free Radical Biology and Medicine, 23(2), 345-350.
324. Wang, Z., Zhang, Y., Banerjee, S., Li, Y., & Sarkar, F. H. (2006). Inhibition of nuclear factor kappab activity by genistein is mediated via Notch-1 signaling pathway in pancreatic cancer cells. International Journal of Cancer, 118(8), 1930-1936.
325. Lin, Y., Shi, R., Wang, X., & Shen, H. M. (2008). Luteolin, a flavonoid with potential for cancer prevention and therapy. Current Cancer Drug Targets, 8(7), 634-646.
326. Shih, Y. W., Chen, P. S., Wu, C. H., Jeng, Y. F., & Wang, C. J. (2007). Alpha-chaconine-reduced metastasis involves a PI3K/Akt signaling pathway with downregulation of NF-kappaB in human lung adenocarcinoma A549 cells. Journal of Agricultural and Food Chemistry, 55(26), 11035-11043.
327. Meadows, G. G. (2012). Diet, nutrients, phytochemicals, and cancer metastasis suppressor genes. Cancer Metastasis Reviews, 31(3-4), 441-454.
328. Liu, R. H. (2004). Potential synergy of phytochemicals in cancer prevention: mechanism of action. Journal of Nutrition, 134(12 Suppl), 3479S-3485S.
329. Lin, Y. G., Kunnumakkara, A. B., Nair, A., Merritt, W. M., Han, L. Y., Armaiz-Pena, G. N., et al. (2007). Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clinical Cancer Research, 13(11), 3423-3430.
330. Kunnumakkara, A. B., Guha, S., Krishnan, S., Diagaradjane, P., Gelovani, J., & Aggarwal, B. B. (2007). Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Research, 67(8), 3853-3861.
331. Kunnumakkara, A. B., Diagaradjane, P., Anand, P., Harikumar, K. B., Deorukhkar, A., Gelovani, J., et al. (2009). Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model. International Journal of Cancer, 125(9), 2187-2197.
332. Aggarwal, B. B., Shishodia, S., Takada, Y., Banerjee, S., Newman, R. A., Bueso-Ramos, C. E., et al. (2005). Curcumin suppresses the paclitaxel-induced nuclear factor-κB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clinical Cancer Research, 11(20), 7490-7498.
333. Gonzales, A. M., & Orlando, R. A. (2008). Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes. Nutrition & Metabolism (London), 5, 17.
334. Banerjee, S., Bueso-Ramos, C., & Aggarwal, B. B. (2002). Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Research, 62(17), 4945-4954.
335. Adhami, V. M., Afaq, F., & Ahmad, N. (2003). Suppression of ultraviolet B exposure-mediated activation of NF-kappaB in normal human keratinocytes by resveratrol. Neoplasia, 5(1), 74-82.
336. Kumar, A., & Sharma, S. S. (2010). NF-kappaB inhibitory action of resveratrol: a probable mechanism of neuroprotection in experimental diabetic neuropathy. Biochemical and Biophysical Research Communications, 394(2), 360-365.
337. Bhat, K. P., & Pezzuto, J. M. (2002). Cancer chemopreventive activity of resveratrol. Annals of the New York Academy of Sciences, 957, 210-229.
338. Estrov, Z., Shishodia, S., Faderl, S., Harris, D., Van, Q., Kantarjian, H. M., et al. (2003). Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood, 102(3), 987-995.
339. Yi, C. O., Jeon, B. T., Shin, H. J., Jeong, E. A., Chang, K. C., Lee, J. E., et al. (2011). Resveratrol activates AMPK and suppresses LPS-induced NF-kappaB-dependent COX-2 activation in RAW 264.7 macrophage cells. Anatomy and Cell Biology, 44(3), 194-203.
340. Wyke, S. M., & Tisdale, M. J. (2006). Induction of protein degradation in skeletal muscle by a phorbol ester involves upregulation of the ubiquitin-proteasome proteolytic pathway. Life Sciences, 78(25), 2898-2910.
341. Narayanan, B. A., Narayanan, N. K., Re, G. G., & Nixon, D. W. (2003). Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets. International Journal of Cancer, 104(2), 204-212.
342. Shishodia, S., Sethi, G., & Aggarwal, B. B. (2005). Curcumin: getting back to the roots. Annals of the New York Academy of Sciences, 1056, 206-217.
343. Kim, S. J., Jeong, H. J., Lee, K. M., Myung, N. Y., An, N. H., Yang, W. M., et al. (2007). Epigallocatechin-3-gallate suppresses NF-kappaB activation and phosphorylation of p38 MAPK and JNK in human astrocytoma U373MG cells. Journal of Nutrition and Biochemistry, 18(9), 587-596.
344. Yang, F., Oz, H. S., Barve, S., de Villiers, W. J., McClain, C. J., & Varilek, G. W. (2001). The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. Molecular Pharmacology, 60(3), 528-533.
345. Isa, N. M., Abdelwahab, S. I., Mohan, S., Abdul, A. B., Sukari, M. A., Taha, M. M., et al. (2012). In vitro anti-inflammatory, cytotoxic and antioxidant activities of boesenbergin A, a chalcone isolated from Boesenbergia rotunda (L.) (fingerroot). Brazilian Journal of Medical and Biological Research, 45(6), 524-530.
346. Makita, H., Tanaka, T., Fujitsuka, H., Tatematsu, N., Satoh, K., Hara, A., et al. (1996). Chemoprevention of 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis by the dietary flavonoids chalcone, 2-hydroxychalcone, and quercetin. Cancer Research, 56(21), 4904-4909.
347. Herencia, F., Ferrandiz, M. L., Ubeda, A., Guillen, I., Dominguez, J. N., Charris, J. E., et al. (1999). Novel anti-inflammatory chalcone derivatives inhibit the induction of nitric oxide synthase and cyclooxygenase-2 in mouse peritoneal macrophages. FEBS Letters, 453(1-2), 129-134.
348. Rojas, J., Paya, M., Devesa, I., Dominguez, J. N., & Ferrandiz, M. L. (2003). Therapeutic administration of 3,4,5-trimethoxy-4′-fluorochalcone, a selective inhibitor of iNOS expression, attenuates the development of adjuvant-induced arthritis in rats. Naunyn-Schmiedeberg's Archives of Pharmacology, 368(3), 225-233.
349. Pandey, M. K., Sandur, S. K., Sung, B., Sethi, G., Kunnumakkara, A. B., & Aggarwal, B. B. (2007). Butein, a tetrahydroxychalcone, inhibits nuclear factor (NF)-kappaB and NF-kappaB-regulated gene expression through direct inhibition of IkappaBalpha kinase beta on cysteine 179 residue. Journal of Biological Chemistry, 282(24), 17340-17350.
350. Chen, T. T., Du, Y. J., Liu, X. L., & Zhu, H. B. (2008). Inhibitory action of hydroxysafflor yellow A on inflammatory signal transduction pathway related factors in rats with cerebral cortex ischemia. Yao Xue Xue Bao, 43(6), 570-575.
351. Harikumar, K. B., Kunnumakkara, A. B., Ahn, K. S., Anand, P., Krishnan, S., Guha, S., et al. (2009). Modification of the cysteine residues in IkappaBalpha kinase and NF-kappaB (p65) by xanthohumol leads to suppression of NF-kappaB-regulated gene products and potentiation of apoptosis in leukemia cells. Blood, 113(9), 2003-2013.
352. Lee, Y. M., Jeong, G. S., Lim, H. D., An, R. B., Kim, Y. C., & Kim, E. C. (2010). Isoliquiritigenin 2′-methyl ether induces growth inhibition and apoptosis in oral cancer cells via heme oxygenase-1. Toxicology in Vitro, 24(3), 776-782.
353. Kim, S. N., Kim, M. H., Min, Y. K., & Kim, S. H. (2008). Licochalcone A inhibits the formation and bone resorptive activity of osteoclasts. Cell Biology International, 32(9), 1064-1072.
354. Chaturvedi, M. M., Kumar, A., Darnay, B. G., Chainy, G. B., Agarwal, S., & Aggarwal, B. B. (1997). Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kappaB activation, IkappaBalpha phosphorylation, and degradation. Journal of Biological Chemistry, 272(48), 30129-30134.
355. Kallifatidis, G., Rausch, V., Baumann, B., Apel, A., Beckermann, B. M., Groth, A., et al. (2009). Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. Gut, 58(7), 949-963.
356. Choi, S., Lew, K. L., Xiao, H., Herman-Antosiewicz, A., Xiao, D., Brown, C. K., et al. (2007). D,L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1. Carcinogenesis, 28(1), 151-162.
357. Davis, J. N., Kucuk, O., & Sarkar, F. H. (1999). Genistein inhibits NF-kappa B activation in prostate cancer cells. Nutrition and Cancer, 35(2), 167-174.
358. Natarajan, K., Manna, S. K., Chaturvedi, M. M., & Aggarwal, B. B. (1998). Protein tyrosine kinase inhibitors block tumor necrosis factor-induced activation of nuclear factor-kappaB, degradation of IkappaBalpha, nuclear translocation of p65, and subsequent gene expression. Archives of Biochemistry and Biophysics, 352(1), 59-70.
359. Shishodia, S., & Aggarwal, B. B. (2004). Guggulsterone inhibits NF-kappaB and IkappaBalpha kinase activation, suppresses expression of anti-apoptotic gene products, and enhances apoptosis. Journal of Biological Chemistry, 279(45), 47148-47158.
360. Natarajan, K., Singh, S., Burke, T. R., Jr., Grunberger, D., & Aggarwal, B. B. (1996). Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proceedings of the National Academy of Sciences of the United States of America, 93(17), 9090-9095.
361. Hahn, W. C., & Weinberg, R. A. (2002). Rules for making human tumor cells. New England Journal of Medicine, 347(20), 1593-1603.
362. Elder, L. T., Klein, S. B., Tavakkol, A., Fisher, G. J., Nickoloff, B. J., & Voorhees, J. J. (1990). Growth factor and proto-oncogene expression in psoriasis. Journal of Investigative Dermatology, 95(5 Suppl), 7S-9S.
363. Chen, A., Xu, J., & Johnson, A. C. (2006). Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene, 25(2), 278-287.
364. Yarden, Y. (2001). The EGFR family and its ligands in human cancer: signalling mechanisms and therapeutic opportunities. European Journal of Cancer, 37, Supplement 4(0), 3-8.
365. Gadgeel, S. M., Ali, S., Philip, P. A., Wozniak, A., & Sarkar, F. H. (2009). Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines. Cancer, 115(10), 2165-2176.
366. Kaneuchi, M., Sasaki, M., Tanaka, Y., Yamamoto, R., Sakuragi, N., & Dahiya, R. (2003). Resveratrol suppresses growth of Ishikawa cells through down-regulation of EGF. International Journal of Oncology, 23(4), 1167-1172.
367. Shimizu, M., Adachi, S., Masuda, M., Kozawa, O., & Moriwaki, H. (2011). Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases. Molecular Nutrition & Food Research, 55(6), 832-843.
368. Chen, A., & Xu, J. (2005). Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR. American Journal of Physiology - Gastrointestinal and Liver Physiology, 288(3), G447-G456.
369. Lev-Ari, S., Starr, A., Vexler, A., Karaush, V., Loew, V., Greif, J., et al. (2006). Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity. Anticancer Research, 26(6B), 4423-4430.
370. Hong, R. L., Spohn, W. H., & Hung, M. C. (1999). Curcumin inhibits tyrosine kinase activity of p185neu and also depletes p185neu. Clinical Cancer Research, 5(7), 1884-1891.
371. Hung, C. M., Su, Y. H., Lin, H. Y., Lin, J. N., Liu, L. C., Ho, C. T., et al. (2012). Demethoxycurcumin modulates prostate cancer cell proliferation via AMPK-induced down-regulation of HSP70 and EGFR. Journal of Agricultural and Food Chemistry, 60(34), 8427-8434.
372. Strimpakos, A. S., & Sharma, R. A. (2008). Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxidants and Redox Signaling, 10(3), 511-545.
373. Wang, S., Yu, S., Shi, W., Ge, L., Yu, X., Fan, J., et al. (2011). Curcumin inhibits the migration and invasion of mouse hepatoma Hca-F cells through down-regulating caveolin-1 expression and epidermal growth factor receptor signaling. IUBMB Life, 63(9), 775-782.
374. Korutla, L., Cheung, J. Y., Mendelsohn, J., & Kumar, R. (1995). Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin. Carcinogenesis, 16(8), 1741-1745.
375. Kanwar, S. S., Yu, Y., Nautiyal, J., Patel, B. B., Padhye, S., Sarkar, F. H., et al. (2011). Difluorinated-curcumin (CDF): a novel curcumin analog is a potent inhibitor of colon cancer stem-like cells. Pharmaceutical Research, 28(4), 827-838.
376. Chang, C. M., Chang, P. Y., Tu, M. G., Lu, C. C., Kuo, S. C., Amagaya, S., et al. (2012). Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2. Oncology Reports, 28(5), 1799-1807.
377. Xia, J., Song, X., Bi, Z., Chu, W., & Wan, Y. (2005). UV-induced NF-kappaB activation and expression of IL-6 is attenuated by (-)-epigallocatechin-3-gallate in cultured human keratinocytes in vitro. International Journal of Molecular Medicine, 16(5), 943-950.
378. Chen, P. C., Wheeler, D. S., Malhotra, V., Odoms, K., Denenberg, A. G., & Wong, H. R. (2002). A green tea-derived polyphenol, epigallocatechin-3- gallate, inhibits IkappaB kinase activation and IL-8 gene expression in respiratory epithelium. Inflammation, 26(5), 233-241.
379. Masamune, A., Kikuta, K., Satoh, M., Suzuki, N., & Shimosegawa, T. (2005). Green tea polyphenol epigallocatechin-3-gallate blocks PDGF-induced proliferation and migration of rat pancreatic stellate cells. World Journal of Gastroenterology, 11(22), 3368-3374.
380. Lim, Y. C., & Cha, Y. Y. (2011). Epigallocatechin-3-gallate induces growth inhibition and apoptosis of human anaplastic thyroid carcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex. Journal of Surgical Oncology, 104(7), 776-780.
381. Farabegoli, F., Papi, A., & Orlandi, M. (2011). (-)-Epigallocatechin- 3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells. Bioscience Reports, 31(2), 99-108.
382. Weber, A. A., Neuhaus, T., Skach, R. A., Hescheler, J., Ahn, H. Y., Schror, K., et al. (2004). Mechanisms of the inhibitory effects of epigallocatechin-3 gallate on platelet-derived growth factor-BB-induced cell signaling and mitogenesis. FASEB Journal, 18(1), 128-130.
383. Zhu, B. H., Chen, H. Y., Zhan, W. H., Wang, C. Y., Cai, S. R., Wang, Z., et al. (2011). (-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer. World Journal of Gastroenterology, 17(18), 2315-2325.
384. Basini, G., Bianco, F., & Grasselli, F. (2005). EGCG, a major component of green tea, inhibits VEGF production by swine granulosa cells. Biofactors, 23(1), 25-33.
385. Jung, Y. D., Kim, M. S., Shin, B. A., Chay, K. O., Ahn, B. W., Liu, W., et al. (2001). EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. British Journal of Cancer, 84(6), 844-850.
386. Masuda, M., Wakasaki, T., Toh, S., Shimizu, M., & Adachi, S. (2011). Chemoprevention of head and neck cancer by green tea extract: EGCG - the role of EGFR signaling and "lipid raft". Journal of Oncology, 2011, 540148.
387. Milligan, S. A., Burke, P., Coleman, D. T., Bigelow, R. L., Steffan, J. J., Carroll, J. L., et al. (2009). The green tea polyphenol EGCG potentiates the antiproliferative activity of c-Met and epidermal growth factor receptor inhibitors in non-small cell lung cancer cells. Clinical Cancer Research, 15(15), 4885-4894.
388. Waleh, N. S., Chao, W. R., Bensari, A., & Zaveri, N. T. (2005). Novel D-ring analog of epigallocatechin-3-gallate inhibits tumor growth and VEGF expression in breast carcinoma cells. Anticancer Research, 25(1A), 397-402.
389. Kwak, I. H., Shin, Y. H., Kim, M., Cha, H. Y., Nam, H. J., Lee, B. S., et al. (2011). Epigallocatechin-3-gallate inhibits paracrine and autocrine hepatocyte growth factor/scatter factor-induced tumor cell migration and invasion. Experimental and Molecular Medicine, 43(2), 111-120.
390. Ludwig, A., Lorenz, M., Grimbo, N., Steinle, F., Meiners, S., Bartsch, C., et al. (2004). The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells. Biochemical and Biophysical Research Communications, 316(3), 659-665.
391. Shimizu, M., Deguchi, A., Lim, J. T., Moriwaki, H., Kopelovich, L., & Weinstein, I. B. (2005). (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clinical Cancer Research, 11(7), 2735-2746.
392. Sartippour, M. R., Heber, D., Zhang, L., Beatty, P., Elashoff, D., Elashoff, R., et al. (2002). Inhibition of fibroblast growth factors by green tea. International Journal of Oncology, 21(3), 487-491.
393. Fridrich, D., Teller, N., Esselen, M., Pahlke, G., & Marko, D. (2008). Comparison of delphinidin, quercetin and (-)-epigallocatechin-3-gallate as inhibitors of the EGFR and the ErbB2 receptor phosphorylation. Molecular Nutrition & Food Research, 52(7), 815-822.
394. Sen, T., & Chatterjee, A. (2011). Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor alpha5beta1 in the process. European Journal of Nutrition, 50(6), 465-478. doi: 10.1007/s00394-010-0158-z.
395. Masuda, M., Suzui, M., Lim, J. T., & Weinstein, I. B. (2003). Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells. Clinical Cancer Research, 9(9), 3486-3491.
396. Herbert, K. J., & Snow, E. T. (2012). Modulation of arsenic-induced epidermal growth factor receptor pathway signalling by resveratrol. Chemico-Biological Interactions, 198(1-3), 38-48.
397. Stewart, J. R., & O'Brian, C. A. (2004). Resveratrol antagonizes EGFR-dependent Erk1/2 activation in human androgen-independent prostate cancer cells with associated isozyme-selective PKC alpha inhibition. Investigational New Drugs, 22(2), 107-117.
398. Lee, M. F., Pan, M. H., Chiou, Y. S., Cheng, A. C., & Huang, H. (2011). Resveratrol modulates MED28 (Magicin/EG-1) expression and inhibits epidermal growth factor (EGF)-induced migration in MDA-MB-231 human breast cancer cells. Journal of Agricultural and Food Chemistry, 59(21), 11853-11861.
399. Majumdar, A. P., Banerjee, S., Nautiyal, J., Patel, B. B., Patel, V., Du, J., et al. (2009). Curcumin synergizes with resveratrol to inhibit colon cancer. Nutrition and Cancer, 61(4), 544-553.
400. Shen, F., Chen, S. J., Dong, X. J., Zhong, H., Li, Y. T., & Cheng, G. F. (2003). Suppression of IL-8 gene transcription by resveratrol in phorbol ester treated human monocytic cells. Journal of Asian Natural Products Research, 5(2), 151-157.
401. Mau, M., Kalbe, C., Wollenhaupt, K., Nurnberg, G., & Rehfeldt, C. (2008). IGF-I- and EGF-dependent DNA synthesis of porcine myoblasts is influenced by the dietary isoflavones genistein and daidzein. Domestic Animal Endocrinology, 35(3), 281-289.
402. Nakamura, H., Wang, Y., Kurita, T., Adomat, H., & Cunha, G. R. (2011). Genistein increases epidermal growth factor receptor signaling and promotes tumor progression in advanced human prostate cancer. PLoS One, 6(5), e20034.
403. Zhu, H., Cheng, H., Ren, Y., Liu, Z. G., Zhang, Y. F., & De Luo, B. (2012). Synergistic inhibitory effects by the combination of gefitinib and genistein on NSCLC with acquired drug-resistance in vitro and in vivo. Molecular Biology Reports, 39(4), 4971-4979.
404. Yan, G. R., Xiao, C. L., He, G. W., Yin, X. F., Chen, N. P., Cao, Y., et al. (2010). Global phosphoproteomic effects of natural tyrosine kinase inhibitor, genistein, on signaling pathways. Proteomics, 10(5), 976-986.
405. Hess, J., Angel, P., & Schorpp-Kistner, M. (2004). AP-1 subunits: quarrel and harmony among siblings. Journal of Cell Science, 117(Pt 25), 5965-5973.
406. Shaulian, E., & Karin, M. (2002). AP-1 as a regulator of cell life and death. Nature Cell Biology, 4(5), E131-E136.
407. Ameyar, M., Wisniewska, M., & Weitzman, J. B. (2003). A role for AP-1 in apoptosis: the case for and against. Biochimie, 85(8), 747-752.
408. Jeong, W. S., Kim, I. W., Hu, R., & Kong, A. N. (2004). Modulation of AP-1 by natural chemopreventive compounds in human colon HT-29 cancer cell line. Pharmaceutical Research, 21(4), 649-660.
409. Lee, J. Y., Moon, S. K., Hwang, C. W., Nam, K. S., Kim, Y. K., Yoon, H. D., et al. (2005). A novel function of benzyl isothiocyanate in vascular smooth muscle cells: the role of ERK1/2, cell cycle regulation, and matrix metalloproteinase-9. Journal of Cellular Physiology, 203(3), 493-500.
410. Dong, Z. (2000). Effects of food factors on signal transduction pathways. Biofactors, 12(1-4), 17-28.
411. Manna, S. K., Mukhopadhyay, A., & Aggarwal, B. B. (2000). Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. Journal of Immunology, 164(12), 6509-6519.
412. Han, S. S., Keum, Y. S., Seo, H. J., & Surh, Y. J. (2002). Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. Journal of Biochemistry and Molecular Biology, 35(3), 337-342.
413. Hou, D. X., Yanagita, T., Uto, T., Masuzaki, S., & Fujii, M. (2005). Anthocyanidins inhibit cyclooxygenase-2 expression in LPS-evoked macrophages: structure-activity relationship and molecular mechanisms involved. Biochemical Pharmacology, 70(3), 417-425.
414. Han, S. S., Keum, Y. S., Seo, H. J., Chun, K. S., Lee, S. S., & Surh, Y. J. (2001). Capsaicin suppresses phorbol ester-induced activation of NF-kappaB/Rel and AP-1 transcription factors in mouse epidermis. Cancer Letters, 164(2), 119-126.
415. Manna, S. K., Sah, N. K., Newman, R. A., Cisneros, A., & Aggarwal, B. B. (2000). Oleandrin suppresses activation of nuclear transcription factor-kappaB, activator protein-1, and c-Jun NH2-terminal kinase. Cancer Research, 60(14), 3838-3847.
416. Manna, S. K., Gad, Y. P., Mukhopadhyay, A., & Aggarwal, B. B. (1999). Suppression of tumor necrosis factor-activated nuclear transcription factor-kappaB, activator protein-1, c-Jun N-terminal kinase, and apoptosis by beta-lapachone. Biochemical Pharmacology, 57(7), 763-774.
417. Cichocki, M., Paluszczak, J., Szaefer, H., Piechowiak, A., Rimando, A. M., & Baer-Dubowska, W. (2008). Pterostilbene is equally potent as resveratrol in inhibiting 12-O-tetradecanoylphorbol-13-acetate activated NFkappaB, AP-1, COX-2, and iNOS in mouse epidermis. Molecular Nutrition & Food Research, 52(Suppl 1), S62-S70.
418. Subbaramaiah, K., Cole, P. A., & Dannenberg, A. J. (2002). Retinoids and carnosol suppress cyclooxygenase-2 transcription by CREB-binding protein/p300-dependent and -independent mechanisms. Cancer Research, 62(9), 2522-2530.
419. Ding, M., Feng, R., Wang, S. Y., Bowman, L., Lu, Y., Qian, Y., et al. (2006). Cyanidin-3-glucoside, a natural product derived from blackberry, exhibits chemopreventive and chemotherapeutic activity. Journal of Biological Chemistry, 281(25), 17359-17368.
420. Hung, L. F., Lai, J. H., Lin, L. C., Wang, S. J., Hou, T. Y., Chang, D. M., et al. (2008). Retinoid acid inhibits IL-1-induced iNOS, COX-2 and chemokine production in human chondrocytes. Immunological Investigations, 37(7), 675-693.
421. Chen, W., Dong, Z., Valcic, S., Timmermann, B. N., & Bowden, G. T. (1999). Inhibition of ultraviolet B-induced c-fos gene expression and p38 mitogen-activated protein kinase activation by (-)-epigallocatechin gallate in a human keratinocyte cell line. Molecular Carcinogenesis, 24(2), 79-84.
422. Yang, G. Y., Liao, J., Li, C., Chung, J., Yurkow, E. J., Ho, C. T., et al. (2000). Effect of black and green tea polyphenols on c-jun phosphorylation and H(2)O(2) production in transformed and non-transformed human bronchial cell lines: possible mechanisms of cell growth inhibition and apoptosis induction. Carcinogenesis, 21(11), 2035-2039.
423. Balasubramanian, S., Efimova, T., & Eckert, R. L. (2002). Green tea polyphenol stimulates a Ras, MEKK1, MEK3, and p38 cascade to increase activator protein 1 factor-dependent involucrin gene expression in normal human keratinocytes. Journal of Biological Chemistry, 277(3), 1828-1836.
424. Aggarwal, B. B., Kumar, A., & Bharti, A. C. (2003). Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Research, 23(1A), 363-398.
425. Zhang, F., Altorki, N. K., Mestre, J. R., Subbaramaiah, K., & Dannenberg, A. J. (1999). Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis, 20(3), 445-451.
426. Mohan, R., Sivak, J., Ashton, P., Russo, L. A., Pham, B. Q., Kasahara, N., et al. (2000). Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. Journal of Biological Chemistry, 275(14), 10405-10412.
427. Chan, M. M., Huang, H. I., Fenton, M. R., & Fong, D. (1998). In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochemical Pharmacology, 55(12), 1955-1962.
428. Duvoix, A., Morceau, F., Delhalle, S., Schmitz, M., Schnekenburger, M., Galteau, M. M., et al. (2003). Induction of apoptosis by curcumin: mediation by glutathione S-transferase P1-1 inhibition. Biochemical Pharmacology, 66(8), 1475-1483.
429. Surh, Y. J., Han, S. S., Keum, Y. S., Seo, H. J., & Lee, S. S. (2000). Inhibitory effects of curcumin and capsaicin on phorbol ester-induced activation of eukaryotic transcription factors, NF-kappaB and AP-1. Biofactors, 12(1-4), 107-112.
430. Dickinson, D. A., Iles, K. E., Zhang, H., Blank, V., & Forman, H. J. (2003). Curcumin alters EpRE and AP-1 binding complexes and elevates glutamate-cysteine ligase gene expression. FASEB Journal, 17(3), 473-475.
431. Lagarrigue, S., Chaumontet, C., Heberden, C., Martel, P., & Gaillard-Sanchez, I. (1995). Suppression of oncogene-induced transformation by quercetin and retinoic acid in rat liver epithelial cells. Cellular and Molecular Biology Research, 41(6), 551-560.
432. Wadsworth, T. L., McDonald, T. L., & Koop, D. R. (2001). Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced signaling pathways involved in the release of tumor necrosis factor-alpha. Biochemical Pharmacology, 62(7), 963-974.
433. Cuendet, M., & Pezzuto, J. M. (2000). The role of cyclooxygenase and lipoxygenase in cancer chemoprevention. Drug Metabolism and Drug Interactions, 17(1-4), 109-157.
434. Ding, X. Z., Hennig, R., & Adrian, T. E. (2003). Lipoxygenase and cyclooxygenase metabolism: new insights in treatment and chemoprevention of pancreatic cancer. Molecular Cancer, 2, 10.
435. Steele, V. E., Holmes, C. A., Hawk, E. T., Kopelovich, L., Lubet, R. A., Crowell, J. A., et al. (1999). Lipoxygenase inhibitors as potential cancer chemopreventives. Cancer Epidemiology, Biomarkers and Prevention, 8(5), 467-483.
436. Baumann, J., von Bruchhausen, F., & Wurm, G. (1980). Flavonoids and related compounds as inhibition of arachidonic acid peroxidation. Prostaglandins, 20(4), 627-639.
437. Chung, E. Y., Kim, B. H., Lee, M. K., Yun, Y. P., Lee, S. H., Min, K. R., et al. (2003). Anti-inflammatory effect of the oligomeric stilbene alpha-Viniferin and its mode of the action through inhibition of cyclooxygenase-2 and inducible nitric oxide synthase. Planta Medica, 69(8), 710-714.
438. Landolfi, R., Mower, R. L., & Steiner, M. (1984). Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Structure-activity relations. Biochemical Pharmacology, 33(9), 1525-1530.
439. Mutoh, M., Takahashi, M., Fukuda, K., Komatsu, H., Enya, T., Matsushima-Hibiya, Y., et al. (2000). Suppression by flavonoids of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells: structure-activity relationship. Japanese Journal of Cancer Research, 91(7), 686-691.
440. Ferrandiz, M. L., & Alcaraz, M. J. (1991). Anti-inflammatory activity and inhibition of arachidonic acid metabolism by flavonoids. Agents and Actions, 32(3-4), 283-288.
441. Williams, C. A., Harborne, J. B., Geiger, H., & Hoult, J. R. (1999). The flavonoids of Tanacetum parthenium and T. vulgare and their anti-inflammatory properties. Phytochemistry, 51(3), 417-423.
442. Miles, E. A., Zoubouli, P., & Calder, P. C. (2005). Differential anti-inflammatory effects of phenolic compounds from extra virgin olive oil identified in human whole blood cultures. Nutrition, 21(3), 389-394.
443. Yasukawa, K., Kaminaga, T., Kitanaka, S., Tai, T., Nunoura, Y., Natori, S., et al. (1998). 3 beta-p-Hydroxybenzoyldehydrotumulosic acid from Poria cocos, and its anti-inflammatory effect. Phytochemistry, 48(8), 1357-1360.
444. de la Puerta, R., Ruiz Gutierrez, V., & Hoult, J. R. (1999). Inhibition of leukocyte 5-lipoxygenase by phenolics from virgin olive oil. Biochemical Pharmacology, 57(4), 445-449.
445. Chen, Y. C., Shen, S. C., Chen, L. G., Lee, T. J., & Yang, L. L. (2001). Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide. Biochemical Pharmacology, 61(11), 1417-1427.
446. Gerhauser, C., Klimo, K., Heiss, E., Neumann, I., Gamal-Eldeen, A., Knauft, J., et al. (2003). Mechanism-based in vitro screening of potential cancer chemopreventive agents. Mutation Research, 523-524, 163-172.
447. Hong, J., Smith, T. J., Ho, C. T., August, D. A., & Yang, C. S. (2001). Effects of purified green and black tea polyphenols on cyclooxygenase- and lipoxygenase-dependent metabolism of arachidonic acid in human colon mucosa and colon tumor tissues. Biochemical Pharmacology, 62(9), 1175-1183.
448. Hong, J., Bose, M., Ju, J., Ryu, J. H., Chen, X., Sang, S., et al. (2004). Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis, 25(9), 1671-1679.
449. Subbaramaiah, K., Chung, W. J., Michaluart, P., Telang, N., Tanabe, T., Inoue, H., et al. (1998). Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. Journal of Biological Chemistry, 273(34), 21875-21882.
450. Sies, H., Schewe, T., Heiss, C., & Kelm, M. (2005). Cocoa polyphenols and inflammatory mediators. American Journal of Clinical Nutrition, 81(1 Suppl), 304S-312S.
451. Kundu, J. K., Na, H. K., Chun, K. S., Kim, Y. K., Lee, S. J., Lee, S. S., et al. (2003). Inhibition of phorbol ester-induced COX-2 expression by epigallocatechin gallate in mouse skin and cultured human mammary epithelial cells. Journal of Nutrition, 133(11 Suppl 1), 3805S-3810S.
452. Hou, D. X., Luo, D., Tanigawa, S., Hashimoto, F., Uto, T., Masuzaki, S., et al. (2007). Prodelphinidin B-4 3′-O-gallate, a tea polyphenol, is involved in the inhibition of COX-2 and iNOS via the downregulation of TAK1-NF-kappaB pathway. Biochemical Pharmacology, 74(5), 742-751.
453. Hou, D. X., Masuzaki, S., Hashimoto, F., Uto, T., Tanigawa, S., Fujii, M., et al. (2007). Green tea proanthocyanidins inhibit cyclooxygenase-2 expression in LPS-activated mouse macrophages: molecular mechanisms and structure-activity relationship. Archives of Biochemistry and Biophysics, 460(1), 67-74.
454. Seeram, N. P., Zhang, Y., & Nair, M. G. (2003). Inhibition of proliferation of human cancer cells and cyclooxygenase enzymes by anthocyanidins and catechins. Nutrition and Cancer, 46(1), 101-106.
455. Subbaramaiah, K., & Dannenberg, A. J. (2003). Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends in Pharmacological Sciences, 24(2), 96-102.
456. De Stefano, D., Maiuri, M. C., Simeon, V., Grassia, G., Soscia, A., Cinelli, M. P., et al. (2007). Lycopene, quercetin and tyrosol prevent macrophage activation induced by gliadin and IFN-gamma. European Journal of Pharmacology, 566(1-3), 192-199.
457. Hartisch, C., Kolodziej, H., & von Bruchhausen, F. (1997). Dual inhibitory activities of tannins from Hamamelis virginiana and related polyphenols on 5-lipoxygenase and lyso-PAF: acetyl-CoA acetyltransferase. Planta Medica, 63(2), 106-110.
458. Maiuri, M. C., De Stefano, D., Di Meglio, P., Irace, C., Savarese, M., Sacchi, R., et al. (2005). Hydroxytyrosol, a phenolic compound from virgin olive oil, prevents macrophage activation. Naunyn-Schmiedeberg's Archives of Pharmacology, 371(6), 457-465.
459. Fogliano, V., & Sacchi, R. (2006). Oleocanthal in olive oil: between myth and reality. Molecular Nutrition & Food Research, 50(1), 5-6.
460. Sekiya, K., & Okuda, H. (1982). Selective inhibition of platelet lipoxygenase by baicalein. Biochemical and Biophysical Research Communications, 105(3), 1090-1095.
461. Laughton, M. J., Evans, P. J., Moroney, M. A., Hoult, J. R., & Halliwell, B. (1991). Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability. Biochemical Pharmacology, 42(9), 1673-1681.
462. MacCarrone, M., Lorenzon, T., Guerrieri, P., & Agro, A. F. (1999). Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity. European Journal of Biochemistry, 265(1), 27-34.
463. Reddy, G. R., Ueda, N., Hada, T., Sackeyfio, A. C., Yamamoto, S., Hano, Y., et al. (1991). A prenylflavone, artonin E, as arachidonate 5-lipoxygenase inhibitor. Biochemical Pharmacology, 41(1), 115-118.
464. Shamim, U., Hanif, S., Ullah, M. F., Azmi, A. S., Bhat, S. H., & Hadi, S. M. (2008). Plant polyphenols mobilize nuclear copper in human peripheral lymphocytes leading to oxidatively generated DNA breakage: implications for an anticancer mechanism. Free Radical Research, 42(8), 764-772.
465. Sarkar, F. H., Adsule, S., Padhye, S., Kulkarni, S., & Li, Y. (2006). The role of genistein and synthetic derivatives of isoflavone in cancer prevention and therapy. Mini Reviews in Medicinal Chemistry, 6(4), 401-407.
466. Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., et al. (1996). Effects of a combination of beta carotene and Vitamin a on lung cancer and cardiovascular disease. New England Journal of Medicine, 334(18), 1150-1155.
467. Eberhardt, M. V., Lee, C. Y., & Liu, R. H. (2000). Antioxidant activity of fresh apples. Nature, 405(6789), 903-904.
468. Kowalczyk, M. C., Kowalczyk, P., Tolstykh, O., Hanausek, M., Walaszek, Z., & Slaga, T. J. (2010). Synergistic effects of combined phytochemicals and skin cancer prevention in SENCAR mice. Cancer Prevention Research (Philadelphia, Pa.), 3(2), 170-178.
469. Tadjalli-Mehr, K., Becker, N., Rahu, M., Stengrevics, A., Kurtinaitis, J., & Hakama, M. (2003). Randomized trial with fruits and vegetables in prevention of cancer. Acta Oncologica, 42(4), 287-293.
470. Zhou, J. R., Yu, L., Zhong, Y., & Blackburn, G. L. (2003). Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice. Journal of Nutrition, 133(2), 516-521.
471. Scandlyn, M. J., Stuart, E. C., Somers-Edgar, T. J., Menzies, A. R., & Rosengren, R. J. (2008). A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate. British Journal of Cancer, 99(7), 1056-1063.
472. Mai, Z., Blackburn, G. L., & Zhou, J. R. (2007). Soy phytochemicals synergistically enhance the preventive effect of tamoxifen on the growth of estrogen-dependent human breast carcinoma in mice. Carcinogenesis, 28(6), 1217-1223.
473. Salonen, J. T., Nyyssonen, K., Salonen, R., Lakka, H. M., Kaikkonen, J., Porkkala-Sarataho, E., et al. (2000). Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. Journal of Internal Medicine, 248(5), 377-386.
474. Suganuma, M., Okabe, S., Kai, Y., Sueoka, N., Sueoka, E., & Fujiki, H. (1999). Synergistic effects of (-)-epigallocatechin gallate with (-)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Research, 59(1), 44-47.
475. Williams, S. N., Shih, H., Guenette, D. K., Brackney, W., Denison, M. S., Pickwell, G. V., et al. (2000). Comparative studies on the effects of green tea extracts and individual tea catechins on human CYP1A gene expression. Chemico-Biological Interactions, 128(3), 211-229.
476. Williams, S. N., Pickwell, G. V., & Quattrochi, L. C. (2003). A combination of tea (Camellia senensis) catechins is required for optimal inhibition of induced CYP1A expression by green tea extract. Journal of Agricultural and Food Chemistry, 51(22), 6627-6634.
477. Wallig, M. A., Heinz-Taheny, K. M., Epps, D. L., & Gossman, T. (2005). Synergy among phytochemicals within crucifers: does it translate into chemoprotection? Journal of Nutrition, 135(12 Suppl), 2972S-2977S.
478. Morre, D. M., & Morre, D. J. (2006). Anticancer activity of grape and grape skin extracts alone and combined with green tea infusions. Cancer Letters, 238(2), 202-209.
479. Sharma, R. A., McLelland, H. R., Hill, K. A., Ireson, C. R., Euden, S. A., Manson, M. M., et al. (2001). Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clinical Cancer Research, 7(7), 1894-1900.
480. Hu, B., Ting, Y., Yang, X., Tang, W., Zeng, X., & Huang, Q. (2012). Nanochemoprevention by encapsulation of (-)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability. Chemical Communications (Cambridge), 48(18), 2421-2423.
481. Siddiqui, I. A., & Mukhtar, H. (2010). Nanochemoprevention by bioactive food components: a perspective. Pharmaceutical Research, 27(6), 1054-1060.
482. Bisht, S., Feldmann, G., Soni, S., Ravi, R., Karikar, C., & Maitra, A. (2007). Polymeric nanoparticle-encapsulated curcumin (" nanocurcumin"): a novel strategy for human cancer therapy. Journal of Nanobiotechnology, 5, 3.
483. Bode, A. M., & Dong, Z. (2009). Cancer prevention research - then and now. Nature Reviews Cancer, 9(7), 508-516.
484. Siddiqui, I. A., Adhami, V. M., Chamcheu, J. C., & Mukhtar, H. (2012). Impact of nanotechnology in cancer: emphasis on nanochemoprevention. International Journal of Nanomedicine, 7, 591-605.
485. Siddiqui, I. A., Adhami, V. M., Ahmad, N., & Mukhtar, H. (2010). Nanochemoprevention: sustained release of bioactive food components for cancer prevention. Nutrition and Cancer, 62(7), 883-890.
486. Mohammad, R. M., Al-Katib, A., Aboukameel, A., Doerge, D. R., Sarkar, F., & Kucuk, O. (2003). Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy. Molecular Cancer Therapeutics, 2(12), 1361-1368.
487. Chisholm, K., Bray, B. J., & Rosengren, R. J. (2004). Tamoxifen and epigallocatechin gallate are synergistically cytotoxic to MDA-MB-231 human breast cancer cells. Anti-Cancer Drugs, 15(9), 889-897.
488. Zhang, Q., Fu, H., Pan, J., He, J., Ryota, S., Hara, Y., et al. (2010). Effect of dietary polyphenon E and EGCG on lung tumorigenesis in A/J mice. Pharmaceutical Research, 27(6), 1066-1071.
489. Li, Y., Ahmed, F., Ali, S., Philip, P. A., Kucuk, O., & Sarkar, F. H. (2005). Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. Cancer Research, 65(15), 6934-6942.
490. Banerjee, S., Zhang, Y., Ali, S., Bhuiyan, M., Wang, Z., Chiao, P. J., et al. (2005). Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. Cancer Research, 65(19), 9064-9072.
491. Li, Y., Ellis, K. L., Ali, S., El-Rayes, B. F., Nedeljkovic-Kurepa, A., Kucuk, O., et al. (2004). Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappaB in BxPC-3 pancreatic cancer cell line. Pancreas, 28(4), e90-e95.
492. Lev-Ari, S., Strier, L., Kazanov, D., Madar-Shapiro, L., Dvory-Sobol, H., Pinchuk, I., et al. (2005). Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Clinical Cancer Research, 11(18), 6738-6744.
493. Azmi, A. S., Banerjee, S., Ali, S., Wang, Z., Bao, B., Beck, F. W., et al. (2011). Network modeling of MDM2 inhibitor-oxaliplatin combination reveals biological synergy in wt-p53 solid tumors. Oncotarget, 2(5), 378-392.
494. Rester, U. (2008). From virtuality to reality - virtual screening in lead discovery and lead optimization: a medicinal chemistry perspective. Current Opinion in Drug Discovery & Development, 11(4), 559-568.
495. Lyne, P. D. (2002). Structure-based virtual screening: an overview. Drug Discovery Today, 7(20), 1047-1055.
496. Irwin, J. J., & Shoichet, B. K. (2005). ZINC - a free database of commercially available compounds for virtual screening. Journal of Chemical Information and Modeling, 45(1), 177-182. doi: 10.1021/ci049714+.
497. Chen, H., Yao, K., Nadas, J., Bode, A. M., Malakhova, M., Oi, N., et al. (2012). Prediction of molecular targets of cancer preventing flavonoid compounds using computational methods. PLoS One, 7(5), e38261.
498. Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., et al. (2000). The protein data bank. Nucleic Acids Research, 28(1), 235-242.
499. Kitano, H. (2002). Computational systems biology. Nature, 420(6912), 206-210.
500. Jung, S. K., Lee, K. W., Byun, S., Lee, E. J., Kim, J. E., Bode, A. M., et al. (2010). Myricetin inhibits UVB-induced angiogenesis by regulating PI-3 kinase in vivo. Carcinogenesis, 31(5), 911-917.
501. Kim, J. E., Lee, D. E., Lee, K. W., Son, J. E., Seo, S. K., Li, J., et al. (2011). Isorhamnetin suppresses skin cancer through direct inhibition of MEK1 and PI3-K. Cancer Prevention Research (Philadelphia, Pa.), 4(4), 582-591.
502. Meng, E. C., Shoichet, B. K., & Kuntz, I. D. (1992). Automated docking with grid-based energy evaluation. Journal of Computational Chemistry, 13(4), 505-524.
503. Feig, M., Onufriev, A., Lee, M. S., Im, W., Case, D. A., & Brooks, C. L., 3rd. (2004). Performance comparison of generalized born and Poisson methods in the calculation of electrostatic solvation energies for protein structures. Journal of Computational Chemistry, 25(2), 265-284.